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ABSTRACT 
 
 The emergence of the multi-drug resistant bacteria and the evolutionary spread of 
the antibiotic resistance genes have become a great concern to human health.  Bacteria 
use various systems in combination or alone in response to environmental stressors and 
stimuli to adapt to changing conditions.  Such systems include the two-component 
regulatory system (TCS) and the type IV secretion system (T4SS).  Microbes use TCSs to 
regulate important functions such as sporulation, chemotaxis, as well as autolysis that 
leads to biofilm formation.  In addition, microbes utilize T4SSs to deliver DNA, protein 
substrates, toxin, and virulence factors, from a donor to a recipient cell.  These systems 
are complex, versatile and have a significant impact to human health as they are a major 
driving force for infection and the spread of antibiotic resistance.  The LytSR TCS from 
Staphylococcus aureus has been found to regulate murein hydrolase activity and autolysis 
by controlling the expression of the lrgAB and cidABC genes.  LytS is predicted to 
autophosphorylate upon a membrane potential change, consequently transferring the 
phosphoryl group to the conserved Asp53 residue on the N-terminal domain of the 
response regulator LytR, leading to the transcription of lrgAB genes.  In this study we 
present the X-ray crystal structure of the N-terminal domain of LytR in apo form and in  
complex with beryllium fluoride.  The identification of dimerization interface residues 
can be utilized to predict modes of dimerization and therefore activation of the protein.  A 
second project focuses on a representative of the conjugative T4SSs, is the F plasmid 
from Escherichia coli, which is responsible for the transfer of virulence and antibiotic 
resistance genes.  Two proteins encoded by the F plasmid, TrbC and TraW, are unique to 
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the F-like plasmids and are essential for the transfer of DNA from a donor cell to a 
recipient cell but their mechanism and function is not known.  Interaction studies of TrbC 
and TraW, as well as crystallization experiments are reported.  These studies suggest that 
the roles of TrbC and TraW are related, and that their interaction is important for the 
functional transfer of DNA in the conjugative process.   
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Chapter 1 
Introduction to Bacterial Evolution and Antibiotic Resistance  
 
1.1 Bacterial Evolution and Antibiotic Resistance 
The number of deaths due to the drug-resistant bacterial infections confirms the 
profoundly disturbing problem of bacterial evolution and antibiotic resistance.  While 
healthcare communities around the world are meant to help humans heal, more than 
200,000 patients visiting a hospital get bacterial infections every year with more than 
8,000 deaths as a result in Canada alone (Zoutman et al., 2003).  The adaptation of 
microorganisms, while advantageous for their survival under adverse conditions 
(Ochman et al., 2000; Wilkins and Frost, 2001) poses significant challenges to human 
health causing infectious diseases and make up ~25% of all annual deaths worldwide 
(Morens et al., 2004).  Intriguing bacterial evolution examples include Clostridium 
difficile, which has been known since 1930s and was recognized as a threat to human 
health in 1978.  It has only been in the last two decades, since 1997, mortality rates 
associated with the pathogenic C. difficile infections have more than tripled (PHAC, 
2013).  In 2011 an outbreak of C. difficile, which cause diarrhea and intestinal colitis, in a 
small community in southern Ontario, Canada, caused 20 deaths within 6 weeks of the 
reported outbreak (CTV, 2011).  In addition, Escherichia coli is the most common 
pathogen affecting patients in hospitals causing urinary tract infections and enterocolitis, 
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in addition to pneumonia and meningitis (Yagi et al., 1997).  A recent outbreak of 
Haemolytic Uraemic Syndrome (HUS) caused by enterohaemorrhagic E. coli (EHEC) in 
Germany resulted in over 3000 cases of infection leading to 52 reported deaths (WHO, 
2011).  In E. coli it has been shown that conjugative recombination, increases rates of 
adaptation by 3-fold under conditions of environmental stress (Davies, 1994).  More 
serious infections are associated with Staphylococcus aureus, which cause the most 
dangerous hospital-acquired infections, most commonly acquired through skin-to-skin 
contact (Boucher et al., 2012).  In the early 1940s penicillin was very effectively used to 
treat illness due to S. aureus, but because of its mass production and its wide use for 
various human infections, the microbes quickly adapted, and today over 90% of human S. 
aureus strains are penicillin-resistant (Olsen et al., 2006, Malachowa & DeLeo, 2010).  
Subsequently, S. aureus is believed to have obtained vancomycin resistance from 
enterococci (facultative anaerobic organisms) leading to the emergence of vancomycin-
resistant S. aureus (VRSA) (Weigel et al, 2003).  Moreover, soon after the introduction 
of the antibiotic methicillin, the emergence of methicillin-resistant S. aureus (MRSA) 
was confirmed (Knight et al., 2012; PHAC, 2013).  The sequence of events leading to 
this bacterial resistance, due to the course of their evolution, makes it easy to predict their 
future, as they will combat whatever means of protection we use against them.  The 
disturbing facts include the fundamental property of S. aureus to asymptomatically 
colonize close to 30% of healthy humans’ skin, making them carriers of infection.  These 
persons are more prone to serious infections in case of failure of the immune system or 
breach of the protective skin layer (Chambers & DeLeo, 2009).  In attempting to keep up 
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with antibiotic resistance in human pathogens, the healthcare community may be 
contributing to its rapid development by prescribing the overuse and misuse of 
antibiotics.  Statistical data show that healthcare associated MRSA infection and 
colonization has been continually increasing, where the infection rate has gone up by 
more than 1,000% from 1995 to 2009 (PHAC, 2013).   
 
1.1.1 Bacterial Adaptation Through Gene Transfer 
The imposed pressures such as the presence of antibiotics has enabled the 
microbes to find adaptive mutations to provide growth advantages through natural and 
adaptive means.  This adaptation is very easily facilitated via the exchange of genetic 
material between cells occurring due to horizontal gene transfer (HGT) and vertical gene 
transfer (VGT) (Figure 1.1).  HGT occurs between eukaryotic cells, prokaryotic or a 
combination of the two from the same generation, where the resistance-determining 
genetic information is transferred to the more susceptible bacterial cells.  In addition, 
these cells when introduced to environmental stressors such as antibiotics, over time, lead 
to the survival of the fittest and proliferation of the new generation of resistant bacteria, 
through lateral or VGT (Malachowa & DeLeo, 2010). 
Trafficking of the genetic material (DNA) as a result of adaptation, induced by 
environmental stressors, is considered to have a major role during HGT in 
microorganisms (Lindsay, 2010).  Most bacteria secrete or intake macromolecules such 
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as proteins, DNA, or protein-DNA complexes across their cell envelope in order to 
ensure their metabolism and adaptation in different environments (Baron & Coombes, 
2007).  DNA fragments that encode various virulence, resistance, as well as enzymes that 
mediate their own transfer and integration into the host DNA are also known as Mobile 
Genetic Elements (MGE; Frost et al., 2005).  The transfer of the MGEs in the form of 
bacteriophages, pathogenicity islands, plasmids, transposons and staphylococcal cassette 
chromosomes, account for the 15-20% of the genome of S. aureus isolates (Lindsay, 
2010).  They are the means of transferring genetic information among and within 
bacterial species.  When comparing the genome sequencing of S. aureus populations their 
distinguished MGE profiles suggest the frequent transfer or loss of whole elements, 
making MGEs a key for identification and keeping track of the genes acquired as a result 
of resistance (Lindsay, 2010).   
The physical process for the intercellular transfer of genomic material between 
microbes occurs through three different pathways: specific transfer mediated by (1) 
bacteriophage transduction, (2) direct contact between cells through conjugation, and (3) 
uptake of free DNA by competent microbes from their environment as transformation 
(Figure 1.2) (Frost et al, 2005; Lindsay 2014).  Transduction is defined as DNA transfer 
mediated by independently replicating bacterial viruses known as bacteriophages.  
Conjugation is a specific process that requires independently replicating genetic elements 
known as conjugative plasmids (such as transposons) to encode proteins that facilitate 
their own transfer and the transfer of other cellular DNA from the host cell to a recipient 
lacking such plasmid DNA through a direct contact via the pilus (Frost et al, 2005).     
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Figure 1.1.  Horizontal and Vertical gene transfer between bacterial cells.  HGT occurs 
within the same generation of cells, due to the transfer of antibiotic resistance genes to 
more vulnerable bacteria.  VGT occurs as a result of pressure induced to the microbes by 
antibiotics destroying the susceptible cells, and allowing the resistant microbes to 
proliferate, passed from parent to progeny cells.  Copied from Malachowa and DeLeo, 
2010. 
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Transformation was the first discovered HGT mechanism involving the non-specific 
transfer of DNA into competent cells that can easily uptake foreign materials via the 
permeable membrane.   
 
1.1.2 Modes of Antibiotic Resistance in Bacteria 
Antibiotics can be naturally occurring or synthetic therapeutic agents that act 
against invasive microorganisms at low concentrations with selective toxicity not 
harming the affected host.  It has been over 80 years since Sir Alexander Fleming 
discovered penicillin from the antibiotic producing fungi (Fleming, 1929); during the 
subsequent twenty years, roughly half of the antibacterial drugs used today would be 
supplied to modern medicine (Davies, 1994). Since the introduction of quinolones in 
1962, such as nalidixic acid used for treatment of genitourinary infections, and more 
recently in the year 2000 the approval of oxazolidinones, used as the last resort for 
treatment of bacterial infections, no new antibiotics made their way to the pharmacy 
shelves (Walsh, 2003).  Overall the rate of traditional antibiotic discovery is in decline 
(Nathan, 2004), and as such more targeted, structure-based methods have emerged to 
develop novel antibiotics (Kuhn et al., 2002; Kan et al., 2005).  However, it is becoming 
a trend that antibiotics, given enough time, will fail to provide the necessary means of 
combating microbes. This is not so much a result of the properties of antibiotics 
themselves, but rather the ability of microbes to obtain the genes necessary for antibiotic 
inhibition or digestion as well as
  7 
 
 
 
Figure 1.2.  DNA and MGE transfer between bacterial cells via the bacteriophages 
transduction (1), plasmid transfer through pilus formation and conjugation (2) and uptake 
of free DNA by competent cells known as transformation (3).  Copied from Frost et al., 
2005. 
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trafficking the drugs out of the cell.  So to a bacterium, development of antibiotic 
resistance is merely a particular adaptation for a given environment.  In addition to 
acquiring antibiotic resistance genes and molecules involved in metabolism, bacterial 
plasmids have acquired resistance to various highly toxic organic and inorganic ions, 
including cadmium, mercury, and arsenate, among others (Jensen & Lyon, 2009). 
Antibiotic resistance in prokaryotes is achieved through five different strategies: 
reduction of membrane permeability to metals and antibiotics; drug and metal 
inactivation and modification; rapid efflux of the metal and antibiotics; mutation of 
cellular targets to lower their sensitivity to the toxic metals and antibiotics; and drug and 
metal sequestration (Table 1.1) (Baker-Austin et al., 2006). 
Prokaryotes employ different systems for survival, adaptation, and normal cell 
function.  While there are numerous systems for various purposes both Two-Component 
Regulatory Systems (TCSs), and bacterial Secretion Systems (SSs) are found to 
contribute indirectly and directly to bacterial antibiotic resistance, respectively.  TCSs 
that may lead to cell autolysis and the release of the extracellular DNA, they make it 
available for other microbes to pick up (Galperin, 2010).  On the other hand, some 
secretions systems are able to directly inject DNA from one bacterial cell to another 
lacking such genetic information (Frost et al., 2005).         
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1.2 Two-Component Signal Transduction Systems 
Bacteria have developed the means to adapt to constantly changing environmental 
conditions by responding to their environmental stimuli.  Such stimuli include nutrients 
such as oxygen, nitrogen, and carbon, in addition to the alterations in temperature, 
osmolarity and acidity.  Two-component signaling systems (TCSs) that function as 
phospho-transfer pathways, have enabled pathogenic bacteria to respond and adapt to the 
changing environmental conditions, which are vital for their survival.  In addition to 
bacteria, TCSs are also found among fungi and plants. These signal transduction systems 
regulate gene expression through transcription, post-transcription, and post-translation 
pathways, in addition to regulating protein-protein interactions (Galperin, 2010).  The 
simplest type of TCSs contains a membrane bound sensory histidine kinase (HK), and a 
two-domain response regulator (RR) while more complicated systems can include 
multiple phosphotransfer reactions and a combination of systems (Toro-Roman et al., 
2005).  The typical mode of action of TCSs commences with the signal sensing or ligand 
binding to the HK, initiating signal transduction, which upon autophosphorylation 
transfers a phosphoryl to its cognate RR at the conserved N–terminal Asp residue, 
affecting the properties of the DNA-binding domain at the C-terminus, thus regulating 
gene expression (Stock et al., 2000) (Figure 1.3).     
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Table 1.1.  Structural and functional characteristics of prokaryotic antibiotic* and metal 
resistance strategies. 
 
Resistance Mechanism  Metal Ions  Antibiotics 
Reduction of permeability  Au, Cu, Zn, Mn, Co, Ag  Cip, Tet, Chlor, β-lactams 
Drug and metal alteration  As, Hg  β-lactams, Chlor 
Drug and metal efflux  Cu, Co, Zn, Cd, Ni, As  Tet, Chlor, β-lactams 
Alteration of cellular targets  Hg, Zn, Cu  Cip, β-lactams, Trim, Rif 
Drug and metal 
sequestration 
Zn, Cd, Cu  CouA 
 
*Antibiotic abbreviations: Cip, ciprofloxacin; Tet, tetracycline; Chlor, chloramphenicol; 
Trim, trimethoprim; Rif, rifampicin; CouA, coumermycin A.  Adapted from Baker-
Austin et al., 2006. 
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1.2.1 Histidine Kinases 
The two-component system Histidine Kinases are catalytically similar to 
Ser/Thr/Tyr protein kinases.  The difference exists in their chemistry where the latter 
create phosphoesters, and the TCS HKs create phosphoramidates.  Given the high 
negative free energy for phosphoramidates (N-P bond), the equilibrium for 
phosphorylation of HKs prefers the unphosphorylated protein, resulting in phosphoryl 
transfer (Stock et al., 1990).  Despite the high-energy barrier, as a result of environmental 
stimuli, HKs efficiently get autophosphorylated during the efflux of phosphoryl groups.  
The ATP-dependent autophosphorylation of HKs involves two homodimers, where one 
HK monomer catalyzes the phosphorylation of the conserved His residue on the second 
monomer (Surette et al., 1996; Pan et al., 1993; Yang et al., 1993; Wolfe et al., 1993).  
Another difference between the HKs and other kinases is that HKs transfer the 
phosphoryl group to a conserved Asp residue of its specific RR of TCSs, unlike other 
types of kinases, which can phosphorylate multiple target RRs.  In addition to 
autophosphorylation and phosphotransfer HK functions include dephosphorylation of 
their cognate RR (Keener & Kustu, 1988). 
HKs are divided into two classes: orthodox and hybrid kinases (Parkinson & 
Kofoid, 1992; Alex & Simon, 1994).  Orthodox HK function as periplasmic membrane 
receptors, which have the N-terminal signal sensing domain and C-terminal catalytic 
kinase core, such as EnvZ from the E. coli involved in osmoregulation (Figure 1.4a).  On 
the other hand, hybrid kinases that are mostly found in eukaryotic systems contain 
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multiple phosphodonor and phosphoacceptor sites, examples include the E. coli anoxic 
redox control ArcB HK (Figure 1.4b).  Orthodox kinases, in addition to being membrane 
bound, they also exist in soluble form functioning in the cytoplasm, such as the 
chemotaxis kinase CheA (Figure 1.4c) (Stock et al, 1988) and the nitrogen regulatory 
kinase NtrB (MacFarlane & Merrick, 1985).  In addition to the regular forms of HK, 
there is also a combination of multiple independent proteins that can convey regulatory 
functions such as the B. subtilis sporulation control (Burbulys et al., 1991)(Figure 1.4d). 
The general structure of transmembrane HKs is composed of the sensing domain, 
linker domain, and the kinase core (Figure 1.4a), EnvZ histidine kinase; sensing domain 
in white, linker domain in black, the kinase core consisting of the five conserved 
residues: H, N, G1, F, G2, in dark grey).  The kinase catalytic domain consists of the 
catalytic ATP-binding domain and the dimerization domain (Stock, 1999).  The catalytic 
ATP-binding domain houses the four conserved residues, N, G1, F and G2 forming the 
highly flexible ATP binding region (Stock & Ninfa, 1989). 
 The dimerization domain holds the sensor His residue, which is located on the 
face of the solvent exposed helix of the dimerization domain of one of the monomers, in 
close proximity to the ATP pocket of the other monomer (Stock et al., 2000).    While the 
kinase core is conserved among different systems, the sensing domain has very low 
sequence similarities with other such domains because of its selective stimuli detection 
(Stock et al., 2000). In addition the linker region connecting the sensor and the catalytic 
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Figure 1.3.  Gene expression as regulated by two-component regulatory systems.  
Sensory information detected by HK is transferred through phosphorylation to the 
Receiver domain of RR, leading to the DNA binding of the effector domain, and gene 
output regulation.  The grey diamonds represent the stimuli sensed by the HK.  Modified 
from Parkinson, 1993. 
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Figure 1.4.  Representative types of orthodox and hybrid HKs.  His-domains in dark 
grey, Asp-domains in light grey, variable domains in white.  (a) the Orthodox HK 
example, from the E. coli EnvZ/OmpR osmoregulatory TCS. (b)  the Hybrid HK 
example, containing multiple His-containing phosphotransfer sites. (c)  An orthodox, 
soluble HK example which upon receiving signal from the cytoplasm CheA, 
phosphorylates the single domain CheY, or the methylesterase CheB.  (d) Alternate 
multicomponent independent protein phosphorelay system from B. subtilis sporulation, 
the phosphate is transferred from either HK, to Spo0F, subsequently to Spo0B before 
reaching the RR Spo0A.  Copied from Stock et al, 2000. 
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domains, although not fully evaluated, appears to have a crucial role for proper signal 
transduction (Atkinson & Ninfa, 1992).    
 
1.2.2 Response Regulators 
The bacterial TCSs regulate and respond to environmental changes using 
phospho-relay pathways, starting with the signal detection by HK and ending with the 
phospho-signal transfer to the terminal component RR.  As the final step for regulating 
the response to different extracellular and intracellular stimuli RRs have many different 
targets, such as regulation of chemotaxis, osmoregulation, nitrogen fixation, in addition 
to antibiotic gene transcription through different types of DNA-biding domains (Galperin, 
2006). 
Response regulators consist of a receiver domain located on the N-terminal end of 
the protein and an effector domain on the C-terminal end of the protein.  While most RRs 
share a similar phospho-acceptor, receiver domain, they differ and are classified into 
subfamilies according to their DNA-binding effector domain (Galperin, 2010).  The RR 
catalyzes the phosphoryl group transfer from the Histidine (His) residue of the HK to a 
conserved Aspartate (Asp) residue on its receiver domain.  In addition to the transfer of 
the phosphate by HK, RRs catalyze the removal of the phosphoryl group independently 
of HK as suggested by the observation of phosphorylation and dephosphorylation of the 
Asp by small molecules such as acetyl phosphate and imidazole phosphate (Lukat et al., 
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1992).  Dephosphorylation is an important function of the receiver domains, as they are 
activated or deactivated by the presence or the removal of the phosphate.  Activation is 
generally triggered by the presence of the phosphoryl group causing major conformation 
changes leading to protein dimerization (Fiedler & Weiss, 1995; McCleary, 1996), higher 
order oligomerization (Weiss et al., 1992) and protein-protein (Welch et al., 1993) or 
protein-DNA interactions (Makino et al., 1989).  Phosphorylation-induced dimerization 
causes major conformational changes on the protein, leading to the DNA binding on the 
effector domain, thus controlling gene regulation (Stock et al., 2000).  In rare cases 
dephosphorylation of the RR can trigger activation as well (Simms et al., 1985), an 
example of this is osmoregulation in yeast, which is activated by RR dephosphorylation 
(Posas & Saito, 1998).   
It has been almost thirty years since the first bacterial RR genes were sequenced 
and their domains identified (Drury & Buxton, 1985).  The most abundant transcriptional 
regulators belong to the OmpR/PhoB family classified by 33% of all RR, characterized 
with a winged helix-turn-helix (wHTH) DNA binding domain (Buckler et al., 2002; 
Galperin, 2006; Galperin, 2010).  The second most abundant family with 18.7% is 
NarL/FixJ, characterized by a typical HTH DNA binding domain (Galperin 2006; 
Noriega et al., 2010; Galperin, 2010).  Both of these types of transcriptional regulators 
are further divided into subfamilies based on the similarities of their output domains 
covering 95.3% of all the characterized RRs. 
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  A much different family of transcription factors is AlgR/AgrA/LytR characterized 
by a non-HTH DNA binding domain, named LytTR domain, covering the remaining 
4.7% of the DNA-binding response regulator proteins (Nikolskaya & Galperin, 2002; 
Sidote et al., 2008) involved in regulation of important virulence factors and toxin 
production in pathogenic bacteria (Rood, 1998; Lizewski et al., 2002; Novick, 2003; 
Dawid et al., 2007; Galperin, 2008).  While the above-mentioned RRs have two domains, 
the stand-alone receiver domains make up ~14% of RR (Galperin, 2006).  The best 
example of stand-alone RRs, which is often used to describe the receiver domains of all 
other RRs, is the chemotaxis protein CheY that regulates the direction of the flagellar 
movement in E. coli (Voltz and Matsamura, 1991; Atkinson & Ninfa, 1992).  Although 
RRs are mainly associated with transcriptional regulators, many of them do not regulate 
transcription directly.  These RRs are enzymatic proteins such as the methylesterase 
CheB, which upon phosphorylation controls receptor methylation levels; other examples 
include protein phosphatases, histine kinases etc.  While CheY and CheB are different 
types of RR they are both regulated by the same HK CheA, and CheB activation involves 
multiple protein-protein interactions (Djordjevic et al., 1998). 
While the protein data bank (PDB) contains numerous structures of different RR 
receiver domains, there are very few available structures for the full-length proteins or for 
the DNA-binding domains; in many cases insolubility and lack of stability of the DNA-
binding domains is to blame (Galperin, 2010).  A representative of the receiver domains 
from different types of RRs is CheY.  The structure of the protein consists of an α/β 
motif, with five-stranded β-sheets surrounded by the five α-helices (Figure 1.5).  The 
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conserved phosphorylation site is on Asp57, located on the solvent exposed loop between 
β3 and α3.  The remaining conserved active site residues include Asp12, Asp13, Thr87 
and Lys109 (Sanders et al., 1992).  While numerous residues are affected by the 
activation of the protein, the signature Tyr106 rotameric states between the active and 
inactive forms, as shown in Figure 1.5, are seen in other RRs as well (Zhu et al., 1997; 
Jiang et al., 1997).  Many similarities exist between different receiver domains but they 
display major differences when forming the active dimers and the residues affected by the 
activation at the dimerization interface.  The dimerization interface between PhoB (from 
the wHTH family) monomers occurs between α4-β5-α5 (Bachhawat et al., 2005).  In FixJ 
(from the HTH family) this dimerization interface occurs between α4-β5 (Birck et al., 
1999).  In ComE (which belongs to the lytTR family) between α4-loop α4-β5  (Boudes et 
al., 2014), whereas in VraR the interaction between helices α1-α5 form this interface 
(Leonard et al., 2013).  While these proteins from different families of RRs have many 
similar functional and structural aspects, they do regulate the transcription of different 
genes and so they have different ways of doing so as suggested by the different modes of 
dimer activation.  
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Figure 1.5.  Structure of the CheY protein (PDB ID: 3CHY) shown as grey cartoon.  The 
conserved residues in the active site are shown in green as sticks.  In addition shown in 
green are the two conformations of Tyr106, in active or inactive forms of the protein. 
Oxygens are shown in red, and Nitrogen atoms in blue.  This figure and all other structure 
figures were generated by using PyMol (Schrodinger, 2010). 
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1.3 Bacterial Secretion Systems 
In response to changing environmental conditions, besides transcription based 
adaptation by TCSs, bacteria also use secretion systems (SS) for adapting into their new 
milieus (Campbell-Valois & Sansonetti, 2014).  Bacteria have evolved specialized SSs to 
support the transfer of macromolecules, DNA, or toxins across their cellular membranes.  
Based on their genes and the virulence effectors that these secretion systems transfer 
different types exist and they are numbered types I through VIII (Chen et al., 2005; Frost 
et al., 2005; Abdallah et al.,2007).  Types I and V secretion systems are relatively 
simplistic, containing 1 to 3 component proteins, while Types II, III and IV are more 
complex (Hazes & Frost, 2008). The type IV secretion system (T4SS) is the most 
complex, containing between 8 and 20 core proteins; bioinformatics has shown that 
T4SSs are ancestrally related to bacterial conjugation systems (Lawley et al., 2003).  
 
1.3.1  Type I Secretion System (T1SS) 
One of the simplest bacterial secretion systems is the type I secretion system 
(T1SS) used by many gram negative bacteria to translocate proteins, pore-forming toxins, 
proteases, and lipases, across both inner and outer membranes into their surroundings 
(Gentschev et al., 2002).  This secretion systems is independent of periplasmic 
intermediates, since the secretion signals recognized by the system are located at the 
carboxy terminus of the secreted proteins (Duong et al., 1996).  The best example is the 
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E. coli α-hemolysin HlyA transfer system from E. coli, which causes urinary tract 
infections, due to its cytolytic and cytotoxic activity against a wide range of mammalian 
cell types (Hueck, 1998).   
T1SSs consist of three proteins: an outer membrane (OM) pore, an inner 
membrane bound ATP-Binding Cassette (ABC) used to power protein secretion, and an 
adapter protein that connects these two components (Henderson et al., 2004).  The 
prototypical T1SS in E. coli is composed of the HlyB (ABC), TolC (OM pore) and HlyD 
(adapter) proteins (Figure 1.6) (Gentschev et al., 2002).  Crystallographic analysis of 
TolC has shown that a TolC trimer forms a 12-stranded antiparallel β-barrel that spans 
the outer membrane, while the periplasm-spanning domain of the protein is composed of 
α-helices.  TolC forms a 140 Å (14 nm) long tunnel 3.5 nm in diameter through which 
effector molecules can travel (Holland et al., 2005). In addition, HlyD has also been 
shown to be trimeric, enabling its interaction with TolC resulting in a structure that spans 
both inner and outer membranes including the periplasmic space (Henderson et al., 
2004). 
 
1.3.2 Type II Secretion System (T2SS)  
The type 2 secretion system (T2SS), first described in Klebsiella oxytoca  in the 
1980s (d’Enfert et al., 1987) is one of the more complex secretion systems in addition to 
being one of the more versatile found in different pathogenic strains.  Unlike other  
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Figure 1.6.  Topological model of the T1SS hemolysin secretion.  In response to HlyA, 
the HlyD trimer interacts with the trimeric TolC forming a trans-periplasmic export 
channel.  ATP hydrolysis by HlyB provides the energy for the transport process and 
secretion of HlyA into the extracellular medium. OM, outer memebrane; IM, inner 
membrane.  Copied from Gentschev  et al., 2002.   
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systems, this does not span both inner and outer membranes but it uses Sec translocon 
pathways to cross the inner membrane.  This system promotes specific transport of folded 
periplasmic proteins in gram negative bacteria, across a channel in the outer membrane.  
For instance, Vibrio cholera employs a T2SS in the secretion of its cholera toxin (Zhang 
et al., 1995), as well as the enteropathogenic E. coli for the secretion of the shiga toxin 
(Johnson et al., 2006). In addition, a T2SS is utilized in the assembly of the type IV pilus 
(T4P), a fibre-like structure that serves multiple roles in the interaction of a bacteria and 
it’s environment, in Pseudomonas aeruginosa (Hazes & Frost, 2008).  T2SS proteins 
have been shown to have homologies to other secretion systems, including the T3SS 
(Bitter et al., 1998) and T4SS (Hazes & Frost, 2008) in addition to archaeal pili and 
flagella.  There are 12-15 genes that encode for a T2SS, the complexity and the various 
components, some of known and many still unknown structure/function, assembled and 
involved in T2SS are shown in Figure 1.7 (Mangayarkarsi & Francetic, 2014). 
The T2SS is utilized to secrete a range of effectors including proteases, cellulases, 
lipases and toxins that destroy various tissues and contribute to disease (Johnson et al., 
2006).  Secretion through a T2SS involves a two-step mechanism; the first step involves 
the ATP-dependant transport into the periplasm across the inner membrane of a protein 
substrate containing an N-terminal signal sequence via the secretion pathway (Henderson 
et al., 2004; Johnson et al., 2006).  Once the protein has reached the periplasmic space, 
the N-terminal signal peptide is cleaved, thereby enabling translocation across the outer 
membrane through the outer membrane secretion complex.  This outer membrane 
complex is a ring-like assembly of an integral membrane protein (for example PulD and  
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Figure 1.7.  T2SS components location and interactions in gram negative bacteria 
envelope.  Components of known structure are shown in cartoon, whereas the unknown 
structures are shown as cylinders or lines.  Known interactions between proteins are 
shown as double arrows. OM,outer membrane; PG, peptidoglycan; IM, inner membrane.  
Copied from Mangayarkarasi & Francetic, 2014. 
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PilQ in V. cholera and P. aeruginosa T2SSs, respectively) that forms a 5-10 nm pore 
through which the toxin or T4P emerges (Hazes & Frost, 2008). 
 
1.3.3  Type III Secretion System (T3SS)  
Numerous gram negative pathogens, including Salmonella typhimurium (Valdez 
et al., 2009) and Burkholderia pseudomallei (Sun & Gan, 2010), use a T3SS to deliver 
effector molecules to target cells.  This system uses a dual function needle at the 
membrane tip for translocation of virulence proteins into a host cell, or as a flagellar hook 
where polymerization of an extracellular filament occurs dedicated for bacterial 
locomotion (Abrusci et al., 2014).  The prototypical T3SS is the Yersina pestis system, 
which delivers the Yop proteins (Michiels et al., 1990).  Often termed the injectisome, 
T3SSs with approximately 30 proteins is one of the more complex secretion systems 
(Henderson et al., 2004).  A defining feature of the T3SS is the needle complex, a 120 nm 
structure that spans both inner and outer membranes of the bacterium (Sun & Gan, 2010). 
The 8 nm wide injectisome needle extends out towards the target cell approximately 60-
80 nm and is analogous to the flagellar hook (Figure 1.8).  Similar to T1SS, the T3SS is a 
Sec-independent secretion system; protein secreted through a T3SS do not contain a 
cleavable signal peptide, which is a hallmark of proteins secreted via Sec-dependent 
pathways (Galán, 1999).  It is through this needle complex that contact dependent 
secretion of effector proteins into the target cell occurs; T3SS effectors have the capacity 
to manipulate the host cell in several ways. For example, some bacteria secrete effector 
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Figure 1.8.  General assembly of the T3SS.  A. A cartoon showing the localization of the 
different system components.  B. Surface view of T3SS from Salmonella typhimurium 
with fitted atomic models of known structures.  Copied from Abrusci et al., 2014. 
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proteins that generate a signal for the host cell to engulf the bacterium allowing for quick 
and efficient access into the host cell machinery and infection of the entire tissue, while 
others modify the host’s cell cycle or induce apoptosis (Gophna, 2003).  
 
1.3.4  Type V Secretion System (T5SS) 
The simplest protein secretion system is the type five secretion system (T5SS).  
Similarly to T2SS, this system does not form a complex through both inner and outer 
membranes, but it uses Sec translocon pathway for two-step secretion.  The transport 
through the inner membrane is in a Sec-mediated fashion, followed by effector self-
translocation through the outer membrane (Henderson et al., 2004).  Generally, members 
of this family contain a signal peptide at the N-terminus mediating transport though the 
inner membrane with an effector domain that exerts biological activity in the extracellular 
space.  In addition a linker domain connects the effector domain and the C-terminal β-
domain that assembles into a transmembrane β-barrel, forming a hydrophilic pore in the 
outer membrane, enabling the effector domain to cross the outer membrane 
(Gawarzewski et al., 2013) (Figure 1.9).  T5SS is one of the most simplistic means of 
exporting adhesins, enzymes, toxins and other virulence factors of varying sizes and 
structures in the extracellular milieu (Oomen et al., 2004).  Although not many 
components are involved, the complete mechanism of these systems is not fully 
developed (Gawarzewski et al., 2013). 
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1.3.5  Type VI Secretion System (T6SS) 
Since 2006 when the type VI secretion system (T6SS) was first described 
(Pukatzki et al., 2006), this system is found in 25% of all sequenced gram negative 
bacteria, making it the most widespread secretion system (Bingle et al., 2008).  T6SSs are 
encoded by 13 conserved components that are required for its function (Zheng & Leung, 
2007).  Structurally, T6SSs span both inner and outer membranes across the periplasm 
through a protein complex whose components have not entirely been elucidated, although 
most proteins identified thus far are employed in the formation of the protein channel that 
facilitates the translocation of substrates across the peptidoglycan layer (Pukatzki et al., 
2009).  Recent EM and crystallographic studies indicate that the T6SS contractile 
injection make them analagous to tailed bacteriophages, suggesting specificity and 
efficiency for these systems (Pukatzki et al., 2007).  The best studied examples of T6SSs 
include the secretion of both, the hemolysin co-regulated protein (Hcp) and the valine-
glycine repeat protein G (VgrG). Hcp forms a hexameric ring structure that polymerizes 
to form a channel wide enough to allow for the secretion of globular proteins up to 50 
kDa in size that are up to 100 nm long (Ballister et al., 2008). The Hcp tube is capped by 
VgrG, which forms a trimer containing a C-terminal triple-stranded β-helix.  The VgrG 
trimer forms a needle shaped structure with a purpose to puncture the target cell 
membrane and enable effector molecule delivery (Figure 1.10). 
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Figure 1.9.  Schematic function of the T5SS.  Brown, Sec translocon; purple, signal 
peptidase; yellow, signal peptide; green beta-barrel; blue, effector domain; red, linker 
domain; violet, periplasmic chaperones; orange, Omp85. 1), peptide chain transported 
through the inner membrane by the Sec translocon. 2) in the periplasm the intermediate 
forms a stable conformation while interacting with chaperones and Omp85. 3) the 
effector domain is translocated through the outer membrane.  Copied from Gawarzewski 
et al., 2013 
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While the T6SS delivered VgrG1, or Hcp proteins from Vibrio Cholerae, 
Agrobacterium tumefaciens, or Edwardsiella tarda, affecting animal, plant or fish, 
respectively, have been reported to have pathogenic effects; these systems can also have a 
bactericidal effect by increasing resistance against gram negative bacteria and unicellular 
eukaryotes (Kapitein & Mogk, 2013).  The delivery of Tse1 and Tse3 peptidoglycan 
degrading effectors, is done by T6SS (Rusell et al., 2012).  These effectors can increase 
bacterial fitness allowing the good bacteria, such as the gastrointestinal tract flora, to 
outcompete pathogenic bacteria.  In addition the T6SS of Pseudomonas augerinosa has 
been found to increase the resistance in the presence of Saccharomyces cerevisiae by 
suppressing growth of yeast cells.  Due to their dual role T6SS are an attractive target for 
the discovery of novel antibacterial therapeutics (Kapitein & Mogk, 2013). 
 
1.3.6  Type VII Secretion System (T7SS) 
While other secretion systems are used by bacteria to export unfolded 
polypeptides or monomeric folded proteins, type seven secretion system (T7SS) is used 
for secretion of a folded multimeric complex (Sysoeva, et al., 2014).  As a recently 
identified secretion system, T7SS initially found in the gram positive Mycobacterium 
tuberculosis affecting bacterial processes such as sporulation, conjugation, and bacterial 
cell wall stability (Sysoeva et al., 2014).  The mycobacterial genome can encode up to 
five of these transport systems, termed ESX-1 to ESX-5; two of these systems, ESX-1 
and ESX-5 are involved in virulence (Abdallah et al., 2007).  In Staphylococcus aureus,  
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Figure 1.10.  Schematic function of the T6SS.  Hcp tubes are engulfed by extended 
VipA/VipB tubules, which act like a viral syringe.  The complex is attached to the cell 
envelope by the membrane associated proteins: TssJ, TssM, DotU, and a baseplate like 
structure.  Contraction of VipA/VipB causes ejection of Hcp and VgrG into the host cell.  
OM, outer membrane; IM, inner membrane; PG, peptidoglycan.  Copied from Kapitein 
and Mogk., 2013. 
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two proteins encoded by ESAT-6 secretion system (T7SS), EsxA and EsxB share 
homology with the ESX-1 genes, and deletion of one gene impairs the secretion of both.  
In both well known human pathogens, Mycobacterium turbeculosis and Staphylococus 
aureus,  ESX secretion was found to be crucial for infection (Anderson et al., 2013). 
Although there is limited structural data of the ESX-1 components, it is assumed 
that they form a multi-subunit cell envelope spanning complex similar to that of type IV 
secretion systems (Abdallah et al., 2007).  It has however been shown through protein-
protein interaction studies that the 6 kDa early secreted antigenic target (ESAT-6) and the 
10 kDa culture filtrate protein (CFP-10) are functionally dependent on one another as 
each protein forms a 2-helix hairpin held together by hydrophobic interactions (Renshaw 
et al., 2005). Both proteins have been shown to be important for the virulence of M. 
tuberculosis, as they are important T-cell antigenic targets.  On the other hand, the T7SS 
protein EsxA and EsxB are negatively regulated by the TCS SaeRS  which control a large 
set of secreted virulence factors as targeted by environmental cues (Anderson et al., 
2013).  Further research in the field will continue to shed light into this unique secretion 
system in which all of the secreted proteins are co-dependent on each other for secretion. 
 
1.3.7 Type VIII Secretion System (T8SS) 
 The final known secretion system is type eight secretion system (T8SS), which is 
recognized in E. coli as being responsible for the formation of aggregative fibers known 
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as curli.  These fibers are primarily involved in bacterial biofilm formation and 
attachment to nonbiotic surfaces (Goyal et al., 2013).  The key component of these 
systems is the formation of the oligomeric secretion channel, formed by lipoprotein 
CsgG, in the outer membrane only similar to the T2SS, and T5SSs.  Curli are 
extracellular fibres of 4 to 7 nm in diameter, involved in cell-to-cell contacts in gram-
negative bacteria (Collinson et al., 1991).  These fibers share biochemical and structural 
characteristics with amyloid fibers, formed of fibrous protein aggregates, causing 
Alzheimer’s and Parkinson’s diseases (Chapman et al., 2002).  Unlike the misfolded 
protein amyloids, curli result from dedicated biosynthetic pathways by the T8SS, and are 
considered as important amyloids for bacterial survival (Desvaux et al., 2009).     
  
1.3.8 Type IV Secretion System (T4SS) 
The type IV secretion system (T4SS) is found in both, gram negative and gram 
positive bacteria to deliver DNA and protein substrates to both prokaryotic and 
eukaryotic cells.  This system is the most complex and versatile secretion system with a 
significant impact on human health; it is the major driving force for infection and the 
spread of antibiotic resistance (Trokter et al., 2014).  According to the various functions 
these systems carry T4SSs are divided into three groups: A) conjugation systems that 
translocate single-stranded DNA to recipient cells in a contact dependent manner, such as 
the F plasmid of E. coli (Lawley et al., 2003; Hazes & Frost, 2008); B) DNA uptake and 
release into the extracellular environment independently of contact with another cell, as 
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seen in C. jejuni, H. pylori and N. gonorhoeae (Alvarez-Martinez & Christie, 2009; 
Christie et al., 2005); and C) effector molecule translocation that deliver protein 
substrates directly into eukaryotic cells, such as tumor inducing Ti plasmid of 
Agrobacterium tumefaciens (Christie et al., 2005), the pertussis toxin Bordetella pertussis 
(Shrivastava & Miller, 2009) or the CagA oncoprotein of Helicobacter pylori (Cascals & 
Christie, 2003) (Figure 1.11).  The ability of T4SSs to deliver proteins and nucleic acids 
is what makes them unique. 
The most studied T4SS are the A. tumefaciens, a tumor inducing (Ti) system, 
consisting of 12 core proteins named VirB1-VirB11 and VirD4, and the E. coli systems 
encoded by the conjugative plasmids F, R1, and pKM101 with up to 20 conserved 
proteins (Christie, 2001; Lawley et al., 2003; Alvarez-Martinez & Christie, 2009).  
Although they deliver different factors, many of the T4SS are closely related to one-
another forming a similar translocation apparatus, varying in subunit number and 
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Figure 1.11.  The versatile T4SS.  Gram negative bacteria utilize T4SSs for a range of 
functions including (a) conjugation (i.e. the E. coli F plasmid), (b) DNA uptake and 
release (i.e. in C. jejuni, H. pylori and N. gonorhoeae) and (c) effector translocation 
(i.e. in A. tumefaciens, B. pertussis or L. pneumophila).  Reproduced from Shala et al., 
2015. 
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composition.  Table 1.2 summarizes the conserved proteins and their homologous 
counterparts encoded by the  three different T4SS plasmids, Ti, Cag and F. 
While a few puzzle pieces of the T4SS assembly and its complex structure have 
been put together, there are still many unknown properties of these systems.  Proteins 
VirB3, VirB6-B10 span both membranes forming the supporting structure for the pilus 
assembly and translocation (Trokter et al., 2014).  Pili are the extracellular appendages 
that are thought to promote contact between donor and recipient cells, and in addition 
serve as a channel for ssDNA delivery, but not required for substrate secretion (Lawley et 
al., 2003)  The pilus itself is made of multiple subunits of VirB2, and the VirB5 pilus-tip 
adhesin, not found in all T4SS types.  VirB1 as a periplasmic protein that functions by 
degrading the peptidoglycan layer, but is also required for pilus synthesis (Trokter et al., 
2014).  ATPases VirB4, VirB11, VirD4 located in the cytoplasm at the base of the 
structure power substrate delivery and pilus formation.  Figure 1.12a shows a schematic 
view of the T4SS assembly, whereas Figure 1.12b shows the available structures and the 
proposed arrangement of numerous T4SS components determined by X-ray 
crystallography or Cryo-EM.  While structural information for numerous T4SS proteins 
are available, there are many other proteins encoded by the F plasmid with no 
homologues found in other T4SSs, such as TrbC and TraW from the F plasmid of E. coli. 
Among other DNA trafficking means, conjugation is known to have contributed to 
the widespread of the resistance genes, such as β-lactamase expressing genes in the 
presence of high antibiotic levels, within the non-resistant microbes in nosocomial and  
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Table 1.2. Proposed function and homologies between proteins encoded by three 
different T4SS plasmids from different bacteria 
 
T4SS System Function / 
Homology Ti Cag F 
Pilin VirB2  CagC TraA 
Cyclase    
Acetylase   TraX 
Lysozyme VirB1  Cagγ Orf169 
Pore VirB3 CagE TraL 
Secretion/ATPase VirB4 CagE TraC 
Pore VirB5 CagL TraE 
Pore VirB6 CagW TraG 
Lipoprotein VirB7 CagT TraV 
Pore VirB8 CagV  
Secretion/pore VirB9 CagX TraK 
Pore VirB10 CagY TraB 
Secretion/ATPase VirB11 Cagα  
Secretion/ATPase VirD4   
Pore   TraF 
Pore   TraH 
Pore   TraW 
Pore   TrbC 
Pore   TraU 
Adhesin   TraN 
Relaxase   TraI 
Transport   TraD 
Relaxase   TraM 
Relaxase   TraY 
Accessory to 
relaxase 
  TraJ 
Copied from: Lawley et al., 2003; Renshaw et al., 
2005; Fischer 2011; Trokter et al., 2014). 
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Figure 1.12. (A)  A schematic diagram of the T4SS system, using A. tumefaciens 
VirB/VirD4 as an example (Copied from Trokter et al., 2014).  VirB7, VirB9, VirB10 
form the core complex, and the pilus formation and extension assembles within the centre 
of the core complex. The complex spans through both inner and outer membranes.  Other 
components are shown as localized in/around the complex.  (B)  The proposed 
combination of T4SS assembly subunits as determined by X-ray or CryoEM (Copied 
from Christie et al., 2014).  The ATPases D4, B11,and B4 each forming hexameric 
structures (brown, green, cyan) are shown at the base of the complex; IMC-inner 
membrane core (lime) and the structure of its subunit B8; Channel and the pilus extension 
(orange) made of B2 subunits, and the structure of B5, pilus tip protein is shown.  In 
addition the core B7/B9/B10, forming a tetradecamer, spans through both inner and outer 
membrane forming a cap at the outer membrane.  The structure of the pore-forming B10, 
antennae projection (AP) protein is magnified. 
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other community settings (Yagi et al., 1997).  Conjugation, as the most important process 
for the horizontal gene transfer between bacterial cells, requires independently replicating 
conjugative plasmids that encode and facilitate their own transfer as well as the transfer 
of other cellular DNA (Frost et al., 1994).  The F plasmid of E. coli was identified by 
Lederberg & Tatum almost 70 years ago (Lederberg & Tatum, 1946), and it is still the 
paradigm for studying bacterial conjugation. All genes necessary for F-mediated 
conjugation are located in the 33.3 kb transfer (tra) region of the ~100 kb F plasmid 
(Frost et al., 1994)  The system assembly in F plasmids is composed of a DNA-
processing complex, the relaxosome, that assembles on the plasmid’s origin of transfer 
(oriT),  and  a T4SS, the transferosome, a secretion channel through which the DNA is 
transferred (Lawley et al., 2003); in addition a coupling protein exists as a link between 
the relaxosome and the transferosome (de la Cruz  et al., 2010). 
The mating pair is stabilized through the interactions of TraNF and TraGF, and F 
plasmid DNA is transferred from donor to recipient cell through a TraBF-TraKF-TraVF 
core complex (Harris et al., 2001) by the ATP-dependent coupling protein TraDF.  DNA 
transfer is initiated through the interaction of the relaxase TraI with the F plasmid at the 
origin of transfer (oriT), which is recruited by TraJ through a binding cleft bounded by a 
5-stranded β-sheet and flexible α-helical domain (Alvarez-Martinez & Christie, 2009).  
Following interaction with TraI and the nicking of plasmid DNA, TraM, which binds 
near the oriT, is recruited. TraM contains a core eight helical bundle which interacts with 
the C-terminal domain of TraD (Lu et al., 2008) for ATP-dependent transfer of the 
ssDNA through the core T4SS complex for transfer.  F plasmid transfer is regulated by a 
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few known environmental stressors, such as the Cpx system, which regulated response to 
extracytoplasmic stress, the cyclic AMP receptor protein Crp, and leucine-responsive 
regulatory protein Lrp that regulate gene expression upon nutritional availability (Frost & 
Koraimann, 2010).  Additional modes of F plasmid regulation is done by the FinO-FinP 
fertility inhibition system, which regulates TraJ expression.  FinP depends upon action of 
the plasmid encoded FinO, in F-like systems finO gene is interrupted, therefore transfer to 
F containing plasmid cells is interrupted (Gubbins et al, 2003).  While structures of the 
main scaffolding proteins of the F conjugative plasmid are known, there are still many 
unclear events, many other  unknown proteins necessary for the assembly of the F 
encoded plasmid into the ssDNA injection syringe. 
 
1.4 Thesis Overview 
 
Both TCS and T4SS are important means acquired by bacteria to ensure their 
survival and adaptation in stressful or new environments.  While both of these systems 
have evolved independently, there is a link between the two, where one is required for the 
activation of the other.  For example in Bartonella henselae, pH restricted expression of 
VirB/D4 T4SS is regulated by the TCS BatR/BatS, which regulate genes necessary for 
the T4SS expression (Québatte et al., 2013).  In another example the TCSs EnvZ/OmpR 
and GrrS/GrrA from Erwinia amylovora, besides regulating polysaccharide production 
and motility, these systems are found to down-regulate flagellar gene expression as 
encoded by the T3SSs in E. coli, Salmonella typhimurium and other bacteria (Li et al., 
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2013).  In addition the phenotypes of the phototaxis mutants suggest that Che-like 
polypeptides control both cell orientation with respect to light and pilus biosynthesis 
(Bhaya et al., 2001).  These systems are connected by numerous examples, although the 
process of either is not well established learning more about one could guide us to 
understanding the other.   
In Chapter 2 of this dissertation, the X-ray structural determination of the TCS 
LytR receiver domain from Staphylococcus aureus, in both native and Beryllium fluoride 
complex forms is detailed.  In Chapter 3, interaction studies between TrbC and TraW, 
two important components for the F T4SS pilus assembly, will be discussed.  In Chapter 
4, the expression, purification and crystallization trials of TrbC and TraW from the F 
plasmid T4SS of Escherichia coli will be examined.  Concluding remarks and a 
discussion of future directions is in Chapter 5, and two appendices on X-ray 
crystallographic methods (Appendix A), and on relevant protein sequence details 
(Appendix B) are presented. 
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Chapter 2 
Structural Analysis of the Apo and Beryllium Fluoride bound N-
terminal Receiver Domain of LytR from Staphylococcus aureus 
 
2.1 Introduction 
Two-component systems (TCSs), that function as phosphorylation pathways, have 
enabled pathogenic bacteria to respond and adapt to changing environmental conditions.  
These signal transduction systems in addition to regulating gene expressions they can 
also regulate protein-protein interactions (Galperin, 2010).  The simplest type of TCS 
contains a membrane bound sensory histidine kinase (HK), and a two-domain response 
regulator (RR) while more complicated systems can include multiple phosphotransfer 
reactions (Toro-Roman et al., 2005).  The diversity of these systems is reflective of their 
diverse RRs.  While most RRs share a similar phosphoacceptor, receiver domain (N-
terminal domain), they differ and are classified into subfamilies according to their DNA-
binding effector domain (C-terminal domain) (Galperin, 2010).  The most abundant 
transcriptional regulators belong to the OmpR/PhoB family, characterized with a winged 
helix-turn-helix (wHTH) DNA binding domain (Buckler et al., 2002; Galperin, 2010).  
The second most abundant family is NarL/FixJ, characterized by a typical HTH domain 
(Noriega et al., 2010; Galperin, 2010).  Both of these types of transcriptional regulators 
are further divided into subfamilies based on the similarities of their output domains 
covering 95.3% of the characterized RRs.  A much different family of transcription 
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factors is the AlgR/AgrA/LytR family, characterized by a non-HTH DNA binding 
domain consisting of mainly β-strands, named the LytTR domain, covering the remaining 
4.7% of the DNA-binding response regulator proteins (Nikolskaya & Galperin, 2002; 
Sidote et al., 2008) involved in regulation of important virulence factors and toxin 
production in pathogenic bacteria (Rood, 1998; Lizewski et al., 2002; Novick, 2003; 
Dawid et al., 2007; Galperin, 2008).   
The variability of TCS in bacteria, and their response to the stress induced by the 
overuse and often misuse of antibiotics may be responsible for the emergence of the 
methicillin-resistant strains of Staphylococcus aureus (MRSA) (Ippolito et al., 2010).  
The two component system LytSR, consisting of LytS and LytR, has been recently 
proposed to function as a sense-response system for detecting subtle changes in the cell’s 
transmembrane potential (Peschel et al., 2001; Patton et al., 2006; Li et al., 2007; 
Sharma-Kuinkel et al., 2009). Changes in the transmembrane potential may be a result of 
the release of numerous cationic antimicrobial peptides (CAMPs) by the human host cells 
defence mechanisms (Peschel, 2002; Voyich et al., 2005).  In a typical TCS, the sensor 
HK, upon detection of transmembrane potential decrease (Sharma-Kuinkel et al., 2009), 
transduces the signal intracellularly by transferring a phosphate to the conserved Asp 
residue of its cognate receiver domain of the RR (Gao et al, 2007; Gao & Stock, 2010).  
The phosphorylation initiates a series of conformational changes in the RR that often 
leads to the dimerization of the RR, which may result in a tighter binding of the effector 
domain to the target promoter, that ultimately modulate the output response of the 
proteins (Gao & Stock, 2010).  LytR is a transcription factor that directly regulates the 
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lrgAB operons, thus affecting cidABC operon (Brunskill & Bayles, 1996), both of which 
are involved in the control of programmed cell death and cell lysis (Groicher et al., 2000; 
Rice et al., 2003).  The gene products of the cid operon enhance murein hydrolysis 
activity (Rice et al., 2003) and antibiotic tolerance, while the lrg genes inhibit these 
processes (Groicher et al., 2000).  Sequence alignment of the receiver domains from 
different families of RRs using Clustal Omega (Sievers et al., 2011) shows the most 
conserved key residues involved in the activation of the protein such as: Asp7, Asp8, 
Asp53, Asn55, Met57, Thr81, His83, Tyr98, Lys101, Pro102 highlighted in black, using 
numbering for LytR (Figure 2.1).  However, variability in the residues involved in the 
dimerization interface, involving α4-loopα4β5-α5, such as Ala87, Val88, Phe91, Glu92, 
Asn94, Arg107, Gln110, and Lys114, shown by the residues highlighted in grey for LytR 
(Figure 2.1), indicates that despite the conserved activation of the proteins, they employ 
different strategies to regulate their target genes.  Moreover, considering the diversity of 
RRs there is a significant variability in the primary structure of receiver domains, thus 
limiting the cross-talk among the receiver and effector domains of the two-component 
systems (Barbieri et al., 2010).   
Currently, structures for three members of AlgR/AgrA/LytR subfamily have been 
reported: LytTR DNA-binding domain of AgrA from Staphylococcus aureus bound or 
unbound to DNA (PDB ID: 3BS1 and 4G4K) (Sidote et al., 2008, Leonard et al., 2012), 
the DNA-binding domain of a putative methyl-accepting/DNA RR from Bacillus cereus 
(PDB ID: 3D6W), and the full length ComED58A, in addition to the receiver domains  
  46 
 
Figure 2.1.  Sequence alignment of LytRN with the following receiver domains of other 
known response regulators: LytR (this work), CheY (PDB ID: 3CHY; Volz & 
Matsumura, 1991), PhoB (2IYN; Sola et al., 2006), spr1814 (4E7O; Park et al., 2012), 
FixJ (1DBW; Gouet et al, 1999), ComE (4MLD; Boudes et al., 2014).  β-strand arrows 
and α-helix sheets correspond to LytR secondary structure.  The star (yellow) indicates 
the conserved Asp, Asp53 in LytR, which gets phosphorylated by LytS.  Highlighted in 
reverse video are residues involved in the activation and stabilization of the active site.  
Highlighted in grey are the residues that are involved in the dimerization interface.  
Diamonds (purple) indicate residues that are affected by the activation/dimerization of the 
protein; star (*) not aligned residues.  Sequences were aligned using Clustal Omega 
(Sievers et al., 2011), and the percentage sequence similarity relative to LytR is shown at 
the end. 
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RECD58A, RECD58E of ComE from Streptococcus pneumoniae (PDB ID: 4CBV, 4ML3, 
and 4MLD) (Boudes et al., 2014).  While the receiver domain of different RRs has been 
found to exist in equilibrium between the active and inactive conformations, commonly 
the phosphorylation of these domains on the conserved Asp residue by the HK, favors the 
active state of the protein (Gardino & Kern, 2007). 
Here we report the structural analysis of the LytR receiver domain, both in its apo 
form (apo-LytRN) and in complex with beryllium fluoride (BeF-LytRN).  Beryllium 
fluoride (BeF3-), a noncovalent complex that resembles the phosphoryl group, when 
bound to the oxygen atom of an Aspartate residue (Chabre 1990; Yan et al., 1999; Cho et 
al., 2001), is routinely used to secure RRs in their active conformations for structural 
characterization.  Previous studies in solution and utilizing native polyacrylamide gel 
electrophoresis indicate that while apo-LytRN remains monomeric, the acetyl phosphate 
activated protein forms dimers (Patel, 2014), suggesting that BeF-LytRN should be 
dimeric thus facilitating an investigation of the mechanism of dimerization by LytRN.    
The structure of LytRN was determined to consist of the general fold of a α/β doubly 
wound pattern (Richardson & Richardson, 1990; Solà et al., 1999), consisting of a central 
five-stranded parallel β-sheet surrounded by five α-helices; helices 2, 3, 4 on one side and 
1 and 5 on the other.  LytRN, in complex with BeF3-, was observed to dimerize utilizing 
similar dimerization interface as the one observed in ComE, from the same LytTR family 
(Boudes et al., 2014).   
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2.2 Materials and methods 
 The methods herein describing the purification of LytRN and the preparation of 
the BeF-LytRN complex were primarily done at 4 °C in the laboratory of Prof. Dasantila 
Golemi-Kotra. All protein crystallization experiments, X-ray diffraction, structure 
solution, refinement and analysis was done in the laboratory of Prof. Gerald F. Audette.   
2.2.1 Expression and Purification of LytRN 
The expression and purification protocols for LytRN were initially developed by 
Kevin H. Patel in the lab of Dr. Golemi-Kotra (Patel, 2014). To express LytRN, the 
pET26b::LytRN vector was previously introduced into E. coli BL21 (DE3) cells (Patel, 
2014).  One mL of a 5 mL overnight culture containing a streak of these cells was used to 
inoculate 1 L of Luria-Bertani (LB) broth supplemented with 50 µg/mL Kananmycin 
(Kan).  Cells were cultured at 37 °C and 200 rpm to mid-log phase growth (OD600=0.5-
0.8).  Prior to induction with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) at 
25 °C for 12 hrs, the culture was cooled to 4 °C.  The cells were harvested by 
centrifugation at 3,300 x g for 20 min at 4 °C. 
To purify LytRN, the cell pellet was resuspended in 1:10 (w/v) lysis/loading buffer 
[20 mM Tris pH 7.5, 5mM MgCl2].  The resuspended cells were lysed by sonication 
(Sonic Dismembrator 500, Fisher Scientific) while cooling on ice for 5 min (10s on/15s 
off).  The insoluble cell lysate was removed by centrifugation at 34,000 x g for 30 min at 
4 °C.  The supernatant was loaded onto a pre-equilibrated 40 mL DEAE column (GE 
Healthcare, in Dr Golemi-Kotra’s lab), and the column was subsequently washed with at 
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least five column volumes of the loading buffer to remove any contaminants.  The bound 
protein was eluted over ten column volumes in a linear gradient to a final concentration 
of 100 % elution buffer [500 mM Tris pH 7.5, 5mM MgCl2] at a flow rate of 3 mL/min, 
where the protein elutes with 50-70% of elution buffer (250-350 mM Tris) as indicated 
by the protein band corresponding to LytRN (molecular weight (MW) of 15,028 Da) 
(Figure 2.2a).  LytRN elution peaks were pooled and concentrated by centrifugation 
(1,240 x g at 4°C) using an Amicon Ultra-3 concentrator (Millipore) to a final volume of 
5 mL.  LytRN was then further purified using ÄKTA Purifier at 4 °C (GE Healthcare, in 
Dr. Golemi-Kotra’s lab) and buffer exchanged into crystallization buffer [100mM Tris 
pH 7.5, 5 mM MgCl2] by size exclusion chromatography (SEC) on a HiPrep 26/60 
Sephacryl S-200 HR gel-filtration column (GE Healthcare, in Dr. Golemi-Kotra’s lab) 
(Figure 2.2b).  Fractions corresponding to LytRN were collected and concentrated to 13 
mg/mL prior to crystallization.  The homogeneity of the protein was determined by 
Coomassie blue staining of an 15% SDS polyacrylamide gel (Figure 2.2). 
 
2.2.2 Preparation of LytRN complex with BeF3-   Previous  studies  have  shown  that  phosphorylation  induces  LytRN dimerization  (Patel,  2014),  and  BeF3‐  a  noncovalent  complex  that  resembles  the phosphoryl  group  when  bound  to  the  side  chain  oxygen  atom  of  an  Aspartate residue is routinely used as a phosphorylation analog to secure RRs in their active conformations for structural characterization (Chabre, 1990; Yan et al., 1999; Cho et 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al., 2001).   The generation of BeF‐LytRN was achieved by adding 5.3 mM BeCl2, 33 mM NaF and 1 mM MgCl2 to the purified LytRN (0.5 mg/mL initial concentration) in an ultracentrifugal  filtration device  (5  kDa MWCO)  (Millipore).    This  solution was concentrated (3,500 x g / 4°C)  to a  final protein concentration of 7 mg/mL, which was  then  loaded  into  a  15% native–polyacrylamide  gel  electrophoresis  (PAGE)  to investigate  protein  oligomerization  (Figure  2.3),  and  used  for  crystallization (Section 2.2.4).   Native‐PAGE analysis of  the BeF‐LytRN complex was performed as follows: purified protein (0.47 mM) was mixed with 2X loading dye (40 mM Tris, pH 
6.8, 80 mM DTT, 0.08% Bromophenol blue, 10% glycerol) at 2:1, 1.5:1, and 1:1 dilution.  
The native gel prepared contains a 15% Acrylamide-Bis acrylamide (19:1) resolving gel, 
and a 4% stacking gel.  After loading the protein samples, they were electrophoresed, at 
100 V for 4 hrs at 4°C, using a native running buffer [85 mM Tris, pH 8.3, and 33 mM 
glycine], and stained with Coomassie blue stain for visualization of the protein bands 
(Patel, 2014).  When the protein was diluted 2:1 (10 µL protein + 5 µL dye = 0.31 mM 
protein) the smearing was visible, contrarily to 1.5:1 (0.28 mM) or 1:1 (0.24 mM) 
dilution of the protein with the gel loading dye.  Since a specific amount of NaF and 
BeCl2 is required for the formation of BeF3-, the dilution of these components in the 
solution does not allow for the complex formation.  Alternatively, these results could be 
due to the dilution of the protein concentration.  Considering that activation/dimerization 
of RRs is a revesible process and the proteins exist in equilibrium between the two states, 
it is most likely that the LytRN in this case oligomerizes in the presence of BeF3- rather 
than just due to the higher protein concentrations.
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Figure 2.2.  Purification of LytRN as analyzed by SDS-PAGE using a 15% gel.  (A) 
Samples analyzed after purification with DEAE column: Lane 1, cytosolic fraction; lane 
2, flough through; lane 3, wash of unbound; lanes 4-9 fractions during 50-70% of elution 
buffer (Patel, 2014). (B) Samples analyzed after purification with SEC: Lane 1, 
concentrated fractions from DEAE column (lanes 6-8, in figure a); lanes 2-3, elution with 
75-125 mL of 100 mM Tris volume; lanes 4-9, elution of LytRN130-175 mL volume of 
buffer. 
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Figure 2.3.  Native-PAGE analysis of the apo-LytRN and BeF-LytRN, both at the same 
concentration of 0.47 mM.  At 2:1 (protein:dye; 0.31 mM) dilution the BeF protein 
smears off the gel indicating oligomerization of the protein; when both samples were 
diluted to 1.5:1 (0.28 mM) this smearing of the +BeF sample is less obvious, but still 
there;  with the 1:1 (0.24 mM) dilution of both samples there is no difference between the 
two, indicating that the oligomerization of the protein +BeF is abolished, when the 
sample is further diluted. 
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2.2.3 Crystallization of apo-LytRN 
The crystallization and initial diffraction studies of apo-LytRN have been reported 
previously (Shala et al., 2013).  Briefly, initial crystallization experiments were 
performed by screening conditions in commercially available kits Crystal Screens 1 and 2 
from Hampton Research (Jancarik & Kim, 1991), and JCSG II from Qiagen (Lesley & 
Wilson, 2005).  The trials were set in 96-well sitting drop plates (Axygen) by hand with 1 
µL protein solution concentrated to 6-13 mg/mL, and mother liquor in a 1:1 ratio over a 
reservoir containing 70 µL mother liquor.  The crystal trays were stored at 22 °C.  These 
trials yielded a number of hits producing numerous thin needle-like crystals (Figure 2.4a) 
from various conditions, most of which contained ammonium or lithium sulfate as the 
precipitant, within 1 day.  The most promising initial crystals were obtained from 0.1 M 
MES monohydrate pH 6.5, 1.6 M Magnesium sulfate heptahydrate.  Optimization of the 
crystallization conditions was performed by varying the precipitant concentration and the 
buffer pH using hanging drop EasyXtal 15 well plates with drop guard crystallization 
supports (Qiagen) and incubating the plates at a lower temperature of 4 °C.  Better 
diffracting crystals grew using 7 mg/mL protein mixed with an equal amount of reservoir 
solution [0.1M MES monohydrate pH 6.5, 1.6 M magnesium sulfate heptahydrate] 
equilibrated against 0.5 mL of the reservoir solution at 4 °C over 6 days.  The single 
crystals grew into rods with maximum dimensions of 410 x 166 x 10 µm3 (Figure 2.4b) 
diffracting up to 2.3Å (Figure 2.4c) (Shala et al., 2013). 
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Figure 2.4.  Crystals of LytRN  (A) Initial crystals formed at room temperature looking as 
thin-like needles, that diffract to ~12 Å. (B) Crystals formed after refining against 
concentration of the precipitant and the pH with the dimensions of 410 x 166 x 10 µm3, at 
4°C. (C) Diffraction image of LytRN. Resolution rings showing up to 2.30Å. 
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2.2.4 Crystallization of LytRN complexed with BeF3- The BeF‐LytRN complex was formed by adding 5.3 mM BeCl2, 33 mM NaF and 
1mM MgCl2  to 7 mg/mL apo‐LytRN  (previously purified and SEC buffer  exchanged into 100 mM Tris, pH 7.5) in an ultracentrifugal filtration device with a molecular mass 
cutoff of 5 kDa (Millipore)  using  a  protocol  initially  developed  by  Prof.  Dasantila Golemi‐Kotra.    Initial crystallization trials for BeF‐LytRN were performed using the 
commercially available Crystal Screen and Crystal Screen 2 (Hampton Research) and the 
JCSG Core Suite II (Qiagen) kits.  Similar conditions as for the native LytRN 
crystallization resulted in BeF3--LytRN complex crystals.  The protein complex formed 
unstable crystals in numerous conditions with ammonium, lithium or magnesium sulfate 
after 1 day of incubation and diffracting only to a resolution of 8 Å.  However, after 
optimization of the protein concentration, the pH and precipitant concentration, better 
crystals more sutable for X-ray diffraction formed in 2 to 3 days, with the dimensions 300 
x 130 x 5 µm3 diffracting to 3.5 Å.  Crystallization of BeF-LytRN in this form was 
achieved by mixing equal volumes of protein (7 mg/mL LytRN in 100mM Tris-HCl, pH 
7.5, 33mM NaF, 5.3 mM BeCl2, and 1 mM MgCl2) and reservoir solution (1.3 M MgSO4 
.7H2O, 0.1 M MES, pH 5.55) and incubating the plates at 4 °C (Figure 2.5).   
To prepare the crystals for data collection, crystals were cryoprotected by soaking 
them in a new drop of reservoir solution supplemented with 20% (v/v) glycerol for 45-60 
s prior to vitrification in liquid nitrogen, in the cold room (4 °C).  Crystals were initially 
screened at home, after which they were shipped to the Canadian Macromolecular 
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Crystallography Facility (CMCF) at the Canadian Light Source (CLS), where they 
diffracted to a resolution of 3.5 Å. 
 
2.2.5 Data Collection for apo-LytRN and BeF-LytRN  
X-ray diffraction data for both LytRN and BeF-LytRN complex were collected at 
the CMCF at the CLS.  Diffraction data for the inactive and BeF3- protein were collected 
on CMCF Beamline 08ID1-1 at 100 K and a wavelength of 0.9795 Å.  The data were 
processed using MOSFLM (Leslie & Powell, 2007) and integrated and scaled using 
AIMLESS and CTRUNCATE (Evans, 2011; Padilla & Yeates, 2003) from the CCP4 
program suite (Winn et al., 2011; SERC, 1994).  The native crystals belong to the space 
group P6122 with unit cell dimensions as follows: a = b = 84.82, c = 157.3 Å, α = β = 
90°, γ = 120° with a Matthew’s coefficient (VM)= 2.77, corresponding to one molecule 
per asymmetric unit.  Crystals of BeF-LytRN belong to C2221 with unit cell dimensions: a 
= 86.76, b = 231.91, and c = 158.35 Å, α = β = γ = 90° and VM = 1.70, corresponding to 
four LytRN molecules per asymmetric unit.  Diffraction data collection statistics are listed 
in Table 2.1. 
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Figure 2.5.  Crystal of BeF-LytRN complex protein, formed in 3 days at 4 °C with the 
dimensions of 300 x 130 x 5 µm, and a different morphology than the native LytRN. 
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Table 2.1.  Summary of Data Collection Statistics 
 
 Apo-LytRN BeF-LytRN 
Space group P6122 C2221 
Unit-cell parameters (Å, °) a = b = 84.82, c = 157.3 a = 86.76, b = 231.91, c = 158.35 
α = β = 90, γ = 120 α = β = γ =90  
Resolution range (Å) 66.56–2.34 (2.44–2.34) 65.39-3.5 (3.83-3.50) 
Total  No. of observations 310181 (32139) 99722 (23649) 
No. of unique reflections 14816 (1619) 20588 (4839) 
Completeness (%) 100 (100) 99.9 (100) 
Average I/σ(I) 14.3 (1.5) 7.2 (1.7) 
Rmeasa 0.114 (2.573) 0.187 (1.712) 
Rp.i.m.b 0.025 (0.571) 0.079 (0.711) 
CC1/2 0.997 (0.937) 0.997 (0.607) 
B Wilson (Å2) 72.2 283.4 
Multiplicity 20.9 (19.9) 4.8 (4.9) 
Mosaicity 0.37 0.75 
 
 
aRmeas = ∑hkl{Nhkl/[Nhkl– 1]}1/2 ∑i|Ihkl,i - <Ihkl,i>| / ∑hkl∑i Ihkl,i. 
bRp.i.m. = ∑hkl{1/[Nhkl – 1]}1/2 ∑i|Ihkl,i-<Ihkl>| / ∑hkl∑i Ihkl,i, where Ihkl,i and <Ihkl>  
represent the diffraction-intensity values of the individual measurements and the 
corresponding mean values, respectively. 
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2.2.6 Structure Determination of apo-LytRN  
The structure for the apo-LytRN was determined using data from 42.7-2.34 Å by 
molecular replacement with Phaser (Storoni et al., 2004) integrated in the CCP4i 
interface, using the structure of MrkE from Klebsiella pneumoniae (PDB ID: 2QV0) as 
the search model.  The SigmaA-weighted 2Fo – Fc  and Fo – Fc  electron density maps 
revealed the position of a sulfate ion coordinated by the active site residues.    After 
several cycles of rigid body and restrained refinements using REFMAC (Murshudov et 
al., 2011), TLS refinement and COOT (Emsley et al., 2004) for visual inspection and 
model building, the final model was refined to 2.34 Å with R/Rfree values of 0.209/0.25, 
respectively.  The final model has 960 non-hydrogen atoms with 13 water molecules and 
1 sulfate ion, and refinement statistics are summarized in Table 2.2.  The average B-
values for the main chain and side chain are 89.7 and 98.3 (Å2), respectively, and for the 
water and the sulfate ions are 94.3 and 132.7, respectively.  While these values seem 
high, there are other reported structures in the PDB with similar B factor values and 
resolution, such as the full length ComE from the LytTR family of RRs (PDB ID: 4CBV; 
Boudes et al., 2014).  In addition, the large observed B-Wilson value from the data 
reduction (Table 2.1) suggests relative disorder in the crystal, resulting in higher overall 
B-values in the final structural model.  The residues and ordered waters were built using 
the automated model-building program ARP/wARP (Cohen et al., 2008) followed by 
manual inspection in COOT.  Residues 119-134 at the C-terminus of the protein were not 
modeled due to the missing electron density for those residues.  The data quality and the 
stereochemistry of the final model were validated using SFCHECK (Vaguine et al., 
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1999), PROCHECK (Laskowski et al., 1993), and EBI-PISA (Krissinel & Henrick, 
2007).  PROCHECK analysis indicates that 97.4% of the residues appear in the most 
favorable regions of stereochemical space, with the remaining 2.6% being in allowed 
regions (Figure 2.6). 
 
2.2.7 Structure Determination of BeF-LytRN  
The structure for the BeF3- complex with LytRN was determined using data from 
14.0-3.50 Å by molecular replacement using the structure of the apo-LytRN as the search 
model.  With four molecules per asymmetric unit, and due to the low resolution, 
automatic non-crystallographic symmetry (NCS) restraints were used during refinement.  
The model was built by iterative cycles of NCS-restraints automatically determined by 
REFMAC and manual rebuilding using COOT using SigmaA-weighted 2Fo – Fc and Fo – 
Fc electron density maps after every cycle.  The final model was refined to 3.50 Å and 
had R/Rfree values of 0.178/0.20 (refinement statistics summarized in Table 2.2).  The 
final model of four monomers, chains A, B, C and D of BeF-LytRN, in the asymmetric 
unit contains 3718 atoms, with 4 BeF3- ions, and 3 Mg2+ ions.  The average B-values 
(main chain / side chain) for chains A, B, C, and D are 130.4/148.1, 129.2/147.8, 
134.3/152.3, and 180.3/194.3 (Å2), respectively, and for the BeF3- and Mg2+ ions are 
143.4 and 114.9 (Å2), respectively.  Due to the overall lower density observed in chain D, 
the Mg2+ ion for that chain could not be modeled.  In addition residues E9, R14, L56, 
M57, D58, and E59 are missing in chain D, with residues, Y18, K36, K72 and E73 
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missing side chains.  The C-terminus of LytRN, which is part of the linker region between 
the LytRN and LytRC (residues 119 – 134) was not modeled in any chain due to the poor 
electron density.  The data quality and the structure stereochemistry were analyzed using 
SFCHECK (Vaguine et al., 1999), PROCHECK (Laskowski et al., 1993), and EBI-PISA 
(Krissinel & Henrick, 2007).  From the PROCHECK analysis, 97.1% of the residues 
appear in the most favorable regions and 2.9% occur in the allowed regions (Figure 2.7). 
 
2.2.8 Accession Numbers 
The coordinates and structure factors for the apo- and BEF-LytRN structures have 
been deposited in the Protein Data Bank with accession codes 4O40 and 4PQM, 
respectively. 
 
2.3 Results and Discussion 
2.3.1 Overall Structures 
The structures of the N-terminal receiver domain of LytR, without and with the 
phosphoryl group analog BeF3- (apo-LytRN & BeF-LytRN) were determined at 2.34 Å 
and 3.5 Å resolution, respectively.  The apo- receiver domain of LytR, (apo-LytRN 
residues 1-134), crystallized in the hexagonal space group, P6122 with one molecule in 
the asymmetric unit (Figure 2.8a).  The structure of the protein was determined by 
molecular (MR) replacement using the regulatory domain of MrkE from Klebsiella 
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pneumoniae (PDB ID: 2QV0) as a search model, and refined at 2.34 Å (refinement 
statistics summarized in Table 2.2).  The stereochemical quality of the final model was 
analyzed using PROCHECK (Laskowski et al., 1993); 97.4% of the residues appear in 
the most favorable regions of stereochemical space, with the remaining 2.6% being in 
allowed regions (Figure 2.6).  The BeF3- complex receiver domain of LytR, (Bef-LytRN 
residues 1-134), crystallized in the orthorhombic space group, C2221 with four molecules 
in the asymmetric unit, chains A, B, C, and D (Figure 2.8b).  The structure of the protein 
was determined using molecular (MR) replacement with apo-LytRN as a search model, 
and refined to a resolution of 3.5 Å (refinement statistics summarized in Table 2.2).  
Stereochemical quality analyzed using PROCHECK indicated that 97.1% of the residues 
appear in the most favorable regions and 2.9% occur in the allowed regions of 
stereochemical space (Figure 2.7).   
The LytR receiver domains (Figure 2.8) displays the typical α/β fold and a (βα)5 
arrangement as observed in majority of other RRs (Park et al., 2012; Milani et al., 2005),   
which is  built by five parallel β strand, assembled in a central β sheet and surrounded by 
five α helices: α2, α3, and α4 on one side, with α1 and α5 on the other.  While the apo- 
form of LytRN forms crystallographic dimer with another molecule from a different unit 
cell, the BeF-LytRN with four molecules in the asymmetric unit forms two non-
crystallographic dimers, all with the same dimerization interface using α4-loopα4β5-α5 
region.   
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Table 2.2.  Summary of Refinement Statistics 
 
 Apo-LytRN BeF-LytRN 
Resolution range (Å) 42.7-2.34 14.0-3.50 
Reflections used 13967 18683 
Rworka 0.209 0.178 
Rfreeb 0.25 0.20 
Average B-factors (Å2) 89.6 99 
No. atoms 960 3718 
Water 13 0 
Sulfate 1 0 
BeF3- 0 4 
Magnesium 0 3 
 
aRWork = ∑hkl||Fobshkl| - |Fcalchkl|| / ∑hkl|Fobshkl| 
bRFree is the cross validation R factor using 5% of reflections 
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Figure 2.6.  Ramachandran plot (Ramakrishnan & Ramachandran, 1965) of the apo-
LytRN structure.  One hundred and thirteen (97.4%) of residues appear in favoured 
region; three (2.6%) in allowed region; 0 residues in outlier region.    
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Figure 2.7.  Ramachandran plot (Ramakrishnan & Ramachandran, 1965) of the BeF3- 
complexed LytRN structure.  Four hundred and thirty nine (97.1%) of residues appear in 
favoured regions; thirteen (2.9%) in allowed regions; zero residues in outlier regions.    
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Figure 2.8.  The two crystal structures of LytRN. (A) Single molecule of apo-LytRN in 
the asymmetric unit. (B) The four monomers observed in a single asymmetric unit of the 
BeF-LytRN complex protein crystals.  Chains A (pink), B (cyan), C (yellow), D (red), 
shown as cartoon; the helices involved in the interface interaction between chains A and 
B, C and D are α4 and α5; helices involved in the interface interaction between chains B 
and C are α2, and α3.  
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All LytRN structures are similar with Root-Mean-Square Deviation (RMSD) values 
between the monomer apo-LytRN and BeF-LytRN 0.407, 0.410. 0.410, and 0.388 Å, 
between chains A, B, C, and D, respectively.  While chains A, B, C, and D from BeF-
LytRN are almost all identical with each other, there is a difference between these 
structures as well as when compared to the apo-LytRN form.  
 
2.3.2 Apo-LytRN Crystallizes in an “Active-like” Form in the Presence of 
Sulfate  
The final native protein structure of LytRN contains residues 1-118, 13 water 
molecules, and one SO42- (Table 2.1).  Residues 119-134 were not modeled due to the 
absence of electron density suggesting general disorder at the C-terminal end of the 
protein.  The solvent density site over the residue Asp8, was initially mapped as Mg2+ 
ion.  However, examination of the B-values of active site side chains during initial stages 
of refinement, namely Nε2 from His83 (107.63 Å2), and Nδ2 of Asn55 (123.00 Å2) 
relative to the SO42- oxygens O4 (126.67 Å2) and O2 (133.94 Å2) respectively (Table 
2.3), as well as the large nonspherical electron density within the active site, and ionic 
environment provided by His83 and Asn55, that a sulfate ion occupies the space.  Indeed, 
the B-value for the refined sulfate ion within the active site (312.7 Å2) is similar to that of 
the above mentioned side chains, with appropriate interatomic distances to those side 
chains, supporting the placement of the sulfate ion within the active site.   
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The well-ordered sulfate ion is centrally located in the most accessible region of 
the active site.  The sulfate ion is coordinated by the Nε amino nitrogen of His83, Nδ of 
the Asn55 amide side chain, and the carboxyl oxygen atoms from the Asp8, and Asp53 
and at least 2 water molecules (Figure 2.8).  The interaction of His83 (located in the β4-
α4 loop) with the sulfate ion, leads to a conformational adjustment of the loop by 
positioning it closer to the active site similar to what is observed in other known 
phosphorylated proteins such as spr1814 and PhoB; this conformational change also 
induces structural alterations on α4 allowing for the stabilization of the α4-β5-α5 
interface (Park et al., 2012; Bachhawat et al., 2005).  In addition, a water molecule (W7) 
bridges between the hydroxyl of the Thr81 side chain, and Nζ of Lys101.  The conserved 
residue Thr81 (Figure 2.9) adopts an active like conformation, moving closer to the 
phosphorylated Asp53 residue, similar to other RRs where it is found to be required for 
signal transduction upon phosphorylation (such as in FixJ; Brick et al., 1999).  In the apo- 
form of LytRN, both Thr81 and His83 have similar conformations as seen in other BeF-
bound RRs (Brick et al., 1999).  It appears that since the sulfate ion is chemically and 
physically similar to PO43-, its presence at the active site core in combination with the 
residues surrounding the active site area, trigger a conformational change that is seen in 
other phosphorylated RRs.  In addition, due to the close contacts between the symmetry 
related molecule, it was determined that the apo-LytRN forms a crystallographic dimer 
with another LytRN molecule using the same dimerization interface as the BeF-LytRN 
dimers.  
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Numerous structural findings of the receiver domains of RR suggest that RRs (full 
length or the N-terminal domain only) exist in equilibrium between active and inactive 
states, and phosphorylation allosterically shifts the equilibrium toward the active state 
(Stock and Da Re, 2000; Stock et al., 2000; West and Stock, 2001; Volkman et al., 2001; 
Milani et al., 2005).  In the apo-LytRN case the sulfate ion is able to have the same 
allosteric effect as phosphate, similar to what is seen by other ions such as Hg2+ in the 
case of unphosphorylated (or without BeF) StyR (PDB ID: 1YIO; Milani et al., 2005) 
and Ca2+ on KdpEN (PDB ID: 1ZH2; Toro-Roman et al., 2005) from FixJ and OmpR 
families, respectively.  Similarly to the structures of PhoB (Bachhawat & Stock, 2007) 
and ComE (Boudes et al., 2014) crystallized in the absence of BeF3-, where the proteins 
were found to form crystallographic dimers, the apo-LytRN in the presence of the sulfate 
ion it dimerizes with a crystallographically related molecule. 
 
2.3.3 Dimerization of LytRN when Crystallized in Complex with BeF3-  
It has been shown the LytRN undergoes dimerization-induced activation in the 
presence of acetyl phosphate by using gel electrophoresis and gel filtration (Patel, 2014).  
In this case incubation of the protein in the presence of beryllium fluoride, which is a 
routinely used phosphoryl group analog (Chabre, 1990; Yan et al., 1999; Cho et al., 
2001), resulted in a dimerization of the protein as well (Figure 2.3); which is most often 
associated with  
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Figure 2.9.  The active site of the apo-LytRN structure.  The conserved active site 
residues are shown as sticks, and the electron density map as a mesh is contoured at 1.5 
σ.  The sulfate ion coordination is shown by dotted lines, interacting with the active site 
residues, His83, Asn55 and Asp8, closely resembling active-like conformation of other 
RRs. 
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activation of RRs.  In the presence of BeF3- and under very similar crystallization 
conditions, LytRN crystals formed with different morphology and space group than the 
apo-LytRN crystals.   While the apo-LytRN crystals have one molecule, the BeF-LytRN 
complex crystals hold four molecules per asymmetric unit (Figure 2.10).  
Two sets of molecules (chains A and B, C and D) form identical two-fold 
symmetric dimers using the α4, loop-α4β5, and α5 interface (Figure 2.10a). In addition a 
two-fold non-crystallographic symmetry axis relates chains B and C through the α2α3 
interface (Figure 2.10b); calculated bond lengths of the B-C interaction residues indicate 
that the interaction interface is too low for significance in functional dimerization.   
The dimer interface as a result of BeF3- complex formation buries a 609 Å2 of 
surface area from each monomer, and it involves the α-helix 4, the loop region between 
α4 and β5, as well as α5.  The dimerization interface involves both hydrophobic and polar 
interactions stabilizing the dimerization of the protein.  This interface, while resembling 
that observed in PhoB (PDB ID: 1ZES) and FixJ (PDB ID: 1D5W), is the closest to that 
observed in ComE belonging to the same subfamily of LytR proteins (PDB ID: 4MLD; 
Boudes, et al., 2014); that include the loop region between α4-β5 (Figure 2.11) unlike 
other family proteins where sheet β5 can be included as well (Park et al., 2012); or a 
completely different interface is observed involving only helices α1 and α5, in VraR and 
NarL (Leonard et al, 2003).  Residues involved in hydrophobic interactions are Ala87, 
Val88, and Phe91, from both molecules A and B; all of them belonging to helix α4.  In 
addition, Nδ2 of Asn94, which is part of the loop region between α4 and β5, forms a  
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Figure 2.10.  The dimerization interface of the BeF3- complexed LytRN structure shown 
in ribbon, relative to the ions at the active site as spheres (Mg, green; Be, yellow; F, 
cyan). (A) The dimerization interface between α4-loopα4β5-α5 as result of activation is 
observed between monomers A (red) and B (black), the same as observed between 
monomers C and D (not shown).  (B) The non-crystallographic dimerization interface 
through α2-α3 between monomers B (black) and C (green) relates the two active LytRN 
dimers (AB and CD) in the asymmetric unit. 
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Figure 2.11.  The LytRN dimer interface (AB dimer) highlighting the ionic and 
hydrophobic interactions in the BeF3- activated LytRN.  The α4-loopα4β5-α5 region of 
both monomers is shown as ribbons, with conserved residues that are involved in 
intermolecular salt bridges (dashed lines) shown in stick model.  Residues involved in 
hydrophobic contacts are shown as spheres (carbons, cyan and magenta; nitrogen, blue; 
oxygen, red). 
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hydrogen bond (2.98 Å) with Oε1 from Gln110 in helix α5.  Nζ of Lys114 (in helix α5) 
forms a hydrogen bond (3.40 Å) with the backbone Oxygen of Phe91.  Oε1 of Glu92 
forms salt bridge interactions with Arg107 Nε, and NH2 (3.77 and 3.11Å, respectively) 
connecting α4 and α5 (Figure 2.11).  Similar interactions are observed between molecules 
C and D, which were also found in the apo-LytRN structure with a crystallographicaly-
related molecule. 
Dimers AB and CD form a tetramer generated by the BC interface (covering an 
area of 584 Å2) related by non-crystallographic two-fold symmetry via the α2, and α3 
face of monomers B and C.  Chains A, B, and C are well defined with continuous 
density, compared to chain D which has an overall lower density, suggesting instability of 
the chain.  Residues 119-134 were not mapped on any chain due to the absent density.  
Four BeF3- ions, and 3 Mg2+ ions were modeled, however one magnesium ion was not 
modelled due to the low density in the active site of the D monomer.  It is worth noting 
that signs of conformational disorder by the segments of broken density in the loop 
regions β1-α1 and β3-α3 of the D monomer, in addition to the absent magnesium ion 
affect the packing of the molecules in the crystal lattice, contributing to the overall low 
resolution structure of the protein in the active form.  In the active site of LytRN the 
presence of BeF3- and Mg2+ complex noncovalently bound to Asp53 was clearly visible 
in the initial electron density map.  The Mg2+ ion is coordinated with the fluoride atom F2 
from the BeF3-, the side chain carbonyl oxygens (Oδ) of Asp8 and Asp53, as well as the 
main chain carbonyl oxygen of Asn55, which are also found conserved in other RRs.  
Water molecules normally satisfy the octahedral coordination of the ion in other higher 
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resolution structures of RR, however due to the low resolution of BeF- LytRN waters 
were not modeled into the structure.  Lys101 forms salt bridges (involving both polar and 
hydrogen interactions) with Asp7 and F1 of BeF3-, in addition F1 of BeF3- forms a 
hydrogen bond with the main chain carbonyl oxygen of the conserved Thr81.  The main 
chain amide of Asn55 forms hydrogen bonds with F3 of BeF3- and the carbonyl oxygen 
of Asn55, which then interacts with the Nε, amino nitrogen of His83 (Figure 2.12).  As a 
result, the orientation of His83 allows for the main chain carbonyl O of His83 residue to 
hydrogen bond with the –OH of Tyr98 (also a conserved residue, see Figure 2.1), 
stabilizing the extended conformation of the β4-α4 loop.  The –OH group of Tyr98 points 
toward the N-terminus of helix α4, stabilizing helix α4, thus resulting in the stabilization 
of the dimerization interface in a similar manner to that observed in other NarL/FixJ or 
OmpR/PhoB family members (Park et al., 2012; Toro-Roman et al., 2005).  Contrarily, 
Phe107 from ComE (PDB ID 4MLD; Boudes et al., 2014) is located in the same area as 
Tyr98 from LytR, interacting with helix α4 through hydrophobic contacts with Ala94, 
located on helix α4, instead of ionic interactions of Tyr98 as seen in LytRN-BEF 
structure. 
 
2.3.4 Insights into Phosphorylation-Induced Activation Mechanism of LytRN  
 Two residues, Thr81 and Tyr98 (LytRN numbering), have been described as 
acting like switch residues during activation of various RRs through alteration in side-
chain orientation upon phosphate binding (Bachhawat & Stock, 2007).  In the apo-LytRN  
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Figure 2.12.  The active site of the BeF3- complexed LytRN.   The conserved monomer A 
active site residues are shown as sticks with oxygen atoms in red, and nitrogen atoms in 
blue. The electron density map is contoured at 1.0 σ. Coordination of the BeF3- and Mg2+ 
ions is shown by dotted lines. 
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and BeF-LytRN structures both Thr81 and Tyr98 exhibit an active-like conformation, due 
to their direct or indirect interaction with the sulfate or beryllium fluoride at the active 
site, respectively (Figures 2.9 & 2.12).  The key residue affecting the position of the two 
residues appears to be His83, which hydrogen bonds (2.62 Å) with the hydroxyl group of  
Tyr98 via the main chain carbonyl oxygen of His83.  While this residue is not strictly 
conserved among RR receiver domains, for instance this residue is Arg85 in PhoB and 
Arg90 in ComE, Glu89 in CheY or Phe83 in spr1814, and His84 in FixJ (Figure 2.13), 
the respective side chains adopt similar conformations as His83 of LytRN (Figure 2.13).   
These residues appear to have an important role in ion coordination at the active site upon 
phosphorylation (Bachhawat et al., 2005; Solà et al., 1999; Park et al., 2012; Birck et al., 
1999).  Figure 2.13a shows an overlay of the side chains of the several receiver domains 
of RRs from different families, such as FixJ, PhoB, CheY, spr1814, and ComE in their 
active forms obtained in complex with BeF3-, or by D58E substitution in ComE, 
compared with the BeF-LytRN (black) and apo-LytRN (yellow), highlighting the differing 
positions that His83 (or equivalent) side chain take upon phosphorylation and their 
respective root-mean-square deviations (RMSD) (Maiorov & Crippen, 1994).  There are 
very few differences between the active site residues of apo-LytRN and BeF-LytRN, 
which show an RMSD of 0.611 Å.  Superposition of other BeF-activated RR receiver 
domains onto LytRN show slightly greater differences with RMSD values of 2.283 Å, 
1.954 Å, 0.790 Å, 2.266 Å, and 3.352 Å for BeF-FixJ, BeF-PhoB, BeF-CheY, BeF-
spr1814 and ComE receiver domain with D58E, respectively (Table 2.3).  The 
differences in side chain conformations between other RRs and BeF-LytRN are similar to  
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Figure 2.13. Comparison of the active site for both BeF-LytRN (black) and apo-LytRN 
(yellow) LytRN labeled residues shown in sticks with other conserved RR residues shown 
as lines.  (A) Comparing LytRN (Asp7, Asp8, Asp53, Thr81, His83, Tyr98, Lys101, 
Pro102) with other active protein structures: FixJ (Asp10, Asp11, Asp54, Thr82, His84, 
Phe101, Lys104, Pro105; PDB ID: 1D5W, magenta), PhoB (Glu9, Asp10, Asp53, Thr83, 
Arg85, Tyr102, Lys105, Pro106; PDB ID: 1ZES, green), CheY (Asp12, Asp13, Asp57, 
Thr87, Glu89, Tyr106, Lys109, Pro110; PDB ID: 1FQW, orange), spr1814 (Glu7, Asp8, 
Asp53, Thr81, Phe83, Tyr100, Lys103; PDB ID: 4E7P, grey) and ComE (Glu7, Asp8, 
Glu58, Thr88, Arg90, Phe107, Lys110; PDB ID: 4MLD, cyan).  Both apo-LytRN and 
BeF-LytRN display similar conformations of the key residues in other active RRs (RMSD 
values for the overlay of these residues are in Table 2.3), stressing that the apo-LytRN 
displays active-like conformation.  (B) Comparing the same LytRN residues with the key 
residues of other apo-inactive RRs receiver domain structures:  FixJ (PDB entry 1DBW, 
magenta), PhoB (2IYN, green), CheY (3CHY, orange), spr1814 (4E7O, grey), and ComE 
(4ML3, cyan).  Again, both apo-LytRN and BeF-LytRN show similar conformations, 
larger differences are observed with other RRs in residues equivalent to Thr81, His83 and 
Tyr98 (RMSD values in Table 2.3). 
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Table 2.3.  Comparison of Receiver Domain Active Site Side Chain Positions 
 
*RMSD =  [{SUM(dii)2}/N]1/2, where dii is the distance between the ith 
atom of structure 1 and the ith atom of structure 2, N is the number of 
atoms matched from each structure (Maiorov & Crippen, 1994). 
 RMSD (Å)* 
LytRN vs. Inactive RRs 
Apo-LytRN BeF-LytRN 
Apo-LytRN 0 0.611 
FixJ 4.330 4.177 
PhoB 3.672 3.551 
CheY 1.319 1.060 
spr1814 3.539 3.261 
ComE 2.099 2.019 
LytRN vs. Active RRs   
BeF-LytRN 0.611 0 
FixJ 2.283 2.158 
PhoB 1.954 2.027 
CheY 0.790 0.467 
spr1814 2.266 2.349 
ComE 3.352 3.315 
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those observed for apo-LytRN, mainly due to the similarity of the active sites between the 
two forms of LytRN.  On the other hand, the RMSD values for the superposition of LytRN 
with the native forms of other RRs (Figure 2.13b) shows greater differences, with RMSD 
values of 4.330 Å, 3.672 Å, 1.319 Å, 3.539 Å, and 2.099 for FixJ, PhoB, CheY, spr1814, 
and ComE, respectively (Table 2.3).  The difference in RMSD values for BeF-LytRN and 
the same RRs is similar to those values with apo-LytRN.  These observations indicate that 
both apo- and BeF-bound LytRN active sites more closely resemble other active-like 
(phosphorylated) RRs than apo/native (unphosphorylated) forms of those receiver 
domains.  With the exception of ComE active and inactive structures, which show lower 
RMSD values of 2.099 Å for inactive, and higher value of 3.352 Å for the active form of 
the protein when compared to LytRN (Table 2.3).  These values result mainly due to the 
H-bond interaction of Arg90 (from the loop region β4-α4) with Glu65 (loop region β3-
α3), in the absence of the conserved Aspartate at the active site, and Histidine from the 
loop region β4-α4 interacting with BeF3- at the active site. 
Figure 2.13 highlights that in both apo-LytRN and BeF-LytRN residues His83, 
Thr81, and Tyr98 adapt conformations similar to that of structures from other 
phosphorylated (active) RR receiver domains.  Conversely, comparison of the LytRN 
structures with other apo/un-phosphorylated RR receiver domains (Figure 2.13b) 
indicates that while most active site residues align well, His83, Thr85, and Tyr98 of 
LytRN, differ significantly.  In addition, the full structure alignment of LytRN-BEF with 
ComE D58E (active form) from the same LytTR family results in an RMSD value of 
3.416 Å.  Crystallization of the native and active forms of the protein was done by 
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phospho mimetic mutation of D58E for active and D58A for inactive (Boudes et al., 
2014), where both structures, similarily to apo-LytRN and BeF-LytRN, resemble each 
other with a low RMSD value of 0.610 Å.   
In apo-LytRN His83 is part of the β4-α4 loop region.  Although this loop region is 
not involved in the dimerization interface in LytRN, the main difference between the BeF-
LytRN and apo-LytRN structures appears to be in the length of this loop region affecting 
the length of helix-α4 (when the loop is shorter, the helix is longer).  In the native LytRN 
residues Gln85 and Tyr86 are part of the β4-α4 loop, whereas in the active form the two 
residues belong to helix-α4, making the helix longer, while shortening the loop in the 
BeF-LytRN structure (Figure 2.14).  The extension of helix α4 is also observed in the 
difference of other active and inactive forms of RRs such as StyR from the FixJ family, 
where the inactive form has a shorter helix α4 (Milani et al., 2005; Birck et al., 1999).   
Similarly the active CheY structure was found to have an extended helix α4 from 6 to 9 
residues (Lee et al., 2001).  This extension of the α4 may allow for the stabilization of the 
dimerization interface through this helix, and it also found to be long in both active and 
inactive forms of ComE structures (Boudes et al., 2014).   
In BeF3- activated structures, the Thr81 (LytRN numbering) fluoride-hydrogen 
bond (Figure 2.12) operates as a switch (Birck et al., 1999), stabilizing the β4-α4 loop, 
and orienting helix α4 to stabilize the homodimer (Robinson et al., 2000).  While the so-
called switch interaction is not observed in apo-LytRN in the absence of BeF3- ion, this  
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Figure 2.14.  Comparing the conformation changes between the apo-LytRN (blue) and 
BeF-LytRN (black).  The main differences occur in helix-α4, where residues Gln85, and 
Tyr86 become part of a helix upon activation.  In addition loop region connecting β5 and 
α5 is affected by residues Pro102 and Phe103, where the Phe103 fills in the cavity 
between the loop and helix-α1, stabilizing the structure. 
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suggests different activation modes and dimerization between the two forms of LytRN 
proteins.  In many RRs, such as FixJ and PhoB, complex formation with BeF3= mediates 
dimerization of the receiver domains to promote DNA binding by the effector domains.  
Considering that these receiver domains of RRs exist in equilibrium between active and 
inactive forms stabilization of the protein with BeF3- and Mg2+ (Solà et al., 1999, Makino 
et al., 1989), which form shorter bonds than SO42-, is more effective than with SO42-.  The 
sulfate, in the case of apo-LytRN, has a similar effect on the active site of the protein as 
BeF3- and Mg2+ ions on the BeF-LytRN; inducing crystallographic dimerization of the 
protein, which is associated with phosphorylation-induced activation, or with high protein 
concentration.  Although many inactive structures of RRs have been determined in 
dimeric form, they are more likely to occur as a result of high protein concentrations (i.e. 
NtrC, StyR, PhoB) and usually have different dimerization interface than the active 
structures (Park et al., 2012,).  The largest difference between apo-LytRN and BeF-LytRN 
is observed in the length of helix α4, and the loop region connecting β5 and α5.  
Although the loop between β5 and α5 is not directly part of the interface, it affects helix 
α5, which is involved in interface interactions and dimer stabilization.  In BeF-LytRN the 
conformation of Phe103, which is located between α1 and loop β5-α5, brings the two 
regions of the protein closer, closing the cavity between α1 and loop β5-α5 (Figure 2.14).  
These data suggest that there can be more than one activation mode of RRs depending on 
the residues at the active site.  In addition, although the receiver domains from different 
RR subfamilies are similar structurally, they employ different dimerization interfaces; the 
LytRN dimer interface more closely resembles ComE from the same family of RRs 
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members (Boudes et al., 2014).  The phosphorylated form of ComE, as described by 
Boudes et al. (2014), from the same family as LytR, was determined to have little effect 
on DNA-bnding affinity therefore activation of the protein, instead it induces 
oligomerization of the protein.  On the other hand, they propose that the dimer interaction 
between two receiver domains of ComE may trigger activation of the LytTR RR, and the 
oligomerization of the inactive form occurs only due to the elevated protein 
concentrations.  While the crystallization results of LytR are similar to ComE, where both 
apo- and BeF- complex structures of LytR resulted in active-like dimers using the similar 
dimerization interface as ComE, it is suggested that both LytTR family proteins ComE 
and LytR may share functional homologies.  Identification of the dimerization interface 
residues that were determined in this work may lead towards new drug developments, for 
blocking LytR protein-protein interactions, in the fight against S. aureus infections.    
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Chapter 3 
Probing the interaction of TraW and TrbC from the Escherichia coli F 
plasmid Type IV Secretion System 
 
3.1 Introduction 
The rapid establishment of antibiotic resistance within a bacterial population is 
largely due to the ability of prokaryotes to share their DNA, not only within the same 
species, but also between unrelated species.  Conjugation, as the most important process 
for horizontal gene transfer, requires independently replicating conjugative plasmids that 
encode and facilitate their own transfer as well as the transfer of other cellular DNA 
between two cells (Lanka & Wilkins, 1995; Frost et al., 2005).  Genes essential for 
conjugative single-stranded DNA transfer of the Escherichia coli K-12 fertility factor, F, 
are encoded within the 33.3kb transfer (tra) region of this 99.159 kb plasmid (Genbank 
accession number: NC002483) (Ippen-Ihler & Minkley, 1986; Moore et al., 1990; Frost 
et al., 1994) (Figure 3.1).  While many of the proteins encoded by this plasmid are 
homologous to other systems such as the tumor inducing (Ti) plasmid of Agrobacterium 
tumefaciens (Christie & Cascales, 2005), the pertussis toxin Bordetella pertussis 
(Shrivastava & Miller, 2009) or the CagA system of Helicobacter pylori (Cascales & 
Christie, 2003), there are twelve proteins that are unique to the F plasmid (Table 1.2).  
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Figure 3.1.  The 33.3 Kb transfer region of the F plasmid.  The genes of the transfer 
region are noted, with capital letters denoting “tra” (i.e. traW) and lower case denoting 
“trb” (i.e. trbc), where the order of the genes is mapped.  Protein function is denoted by 
colour, shown below the map.  The position of TraW (W), and TrbC (c) are indicated by 
the red arrows; both proteins involved in the pilus synthesis assembly.  Copied from Frost 
et al., 1994. 
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 A key component initiating the F-mediated conjugation is the F-pilus (made of 
multiple TraA subunits), which is assembled through a T4SS, that mediates contact 
between a F+ donor cell and a F-recipient. Subsequent to this contact, a mating pair 
bridge is formed that mediates DNA transfer through the pilus that also serves as a 
channel for ssDNA transfer during conjugation (Lawley et al., 2003; Schröder & Lanka, 
2005; Babić et al., 2008).  Although energetically expensive, conjugative DNA transfer is 
highly regulated responsive to physiological and environmental stimuli, controlled by the 
interaction and communication of numerous F plasmid proteins (Frost & Manchak, 
1998).  While DNA processing and plasmid transfer from a donor to recipient cell have 
been well studied, the details regarding the interactions occurring within the proteins of 
the T4SS leading to Mpf and plasmid transfer remain relatively unclear (Arutyunov & 
Frost, 2013).  For many of the transfer proteins of the F T4SS, their overall role in F-
mediated conjugation is known and can be related to other homologues of similar 
systems, however detailed information into their functions and particular interactions in 
the complex formation and orchestration of the pilus assembly, pore formation, and Mpf 
are less well characterized.  The general proposed organization of the proteins forming 
the T4SS machinery in shown in Figure 3.2. 
The periplasmic proteins TraW and TrbC (Figure 3.2, shown in cyan, W and c, 
respectively) are unique to F-like systems with no homologues in other similar systems 
and are required for F-pilus assembly and DNA transfer proficiency.  They play an 
important role in Mpf during conjugation (Maneewannakul et al., 1987; Maneewannakul 
et al., 1991; Lawley et al., 2003).  In several systems, including the R27 (Salmonella 
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Figure 3.2.  Model of T4SS system assembly as encoded by the F plasmid of E. coli.  
These proteins are involved in the retraction, of the F pilus (grey), stabilization of the 
mating pair, as well as conjugative DNA transfer.  Copied from Lawley et al, 2003. 
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typhimurium (Sherburne et al., 2000), Rts1 (Proteus vulgaris (Murata et al., 2002)), R391 
(Providencia rettgeri (Böltner et al., 2002)) and SXT (Vibrio cholerae (Beaber et al., 
2002)) plasmids, TrbC is fused into the N-terminal end of TraW.  Conversely, in F (Frost 
et al., 1994), pED208 (Salmonella typhimurium; Lu et al., 2002), UWE25 
(Protochlamydia amoebophila; Greub et al., 2004) and pNL1 (Novosphingobium 
aromaticivorans; Romine et al., 1999) plasmids, TraW and TrbC are expressed as 
separate proteins, where TraW is encoded upstream to TrbC (Figure 3.3).  This suggests 
that these proteins may have a common function and potentially interact even when 
expressed separately (Anthony et al., 1999; Lawley et al., 2003; Greub et al., 2004; 
Arutyunov et al., 2010; Ramsey et al., 2012).  Sequence alignment of TraW/TrbC 
proteins, when expressed as a single or two separate polypeptides, (Figure 3.4) suggests 
that (a) the proteins interact for proper T4SS function when expressed separately, and (b) 
that this interaction is likely through the C-terminal region of TrbC to TraW.  In R27 and 
SXT systems, the gene sequence is continuous (Figure 3.4, the two top sequences), 
whereas TrbC and TraW, highlighted in grey and black, respectively, in pED208 and F 
are expressed separately as encoded by two different genes.   
Yeast two-hybrid analysis has confirmed the interaction between some of the 
proteins in the periplasm, including TraW-TrbB and TraW-TraU interactions (Figure 
3.5), but no association between TrbC and other proteins could be observed (Harris & 
Silverman, 2004).  To date, there are no published results to indicate interaction between 
the two proteins, but in the current study we confirm the interaction between TrbC and 
TraW, and demonstrate the preferred interaction of TraW with the N-terminus of TrbC
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Figure 3.3.  Comparing the genes of the F-like systems.  TraW (W) and TrbC (c) (red 
arrows) are fused in R27, Rts1, R391, and SXT, whereas in F factor, pED208, and pNL1 
they are separate polypeptides.  Copied from Lawley et al., 2003. 
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Figure 3.4.  Sequence alignment of TraW and TrbC from several F-like T4SSs.  
TraW/TrbC is expressed as a single polypeptide in the R27 and SXT systems, however in 
F and pED208, TraW (highlighted in black) and TrbC (highlighted in grey) are expressed 
separately. The alignments was produced using Clustal Omega (Sievers et al., 2011) 
using the following Uniprot accession numbers: TrhW-R27 (NP_058221.1); TraW-SXT 
(AAL59671.1); TrbC-F (NP_061467.1); TrbC-pED208 (AAM90718.1); TraW-F 
(NP_061465.1); TraW-pED208 (AAM90715.1). 
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Figure 3.5.  Periplasmic protein interactions as determined by yeast two-hybrid analysis.  
tra  proteins are denoted in capital letters, such as W for TraW, which is shown to interact 
with TrbB and TraU; as indicated by arrows.  Copied from Harris & Silverman, 2004. 
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versus the C-terminus. It was also determined that this interaction is independent of the 
presence or absence of N-terminal purification tags. 
 
3.2 Materials and Methods 
3.2.1 Construction of N-terminally 6-His tagged TraW and TrbC 
Several initial constructs, including the pMALp2 vector harbouring N-terminally 
MBP-tagged TrbC (MBP-TrbC) and pT7-7 vectors harbouring C-terminally 7-His tagged 
TraW and TrbC (TraW-His7 and TrbC-His7), were kindly provided by Dr. Laura Frost 
(University of Alberta). The traW gene encoding the mature protein, from protein ID: 
NP_061465.1 (residues 19-210) was PCR amplified by Vent polymerase (New England 
Biolabs; NEB) using forward primer 5’-GCCCATATGGCCGATCTTGGTACCTGG-3’ 
containing an NdeI site (italics) and reverse primer 5’-
GGCCAAGCTTGTTATTTTCTGCCCTCC-3’ containing an HindIII site (italics). 
Similarly, the trbC gene encoding the mature protein, protein ID: NP_061467.1 (residues 
22-212) was PCR amplified using forward primer 5’-
GCCCATATGTCAGAAAACGTGAACAC-3’ containing an NdeI site and reverse 
primer 5’-GCAAGCTTTTATTTCCCGGAATCTCCT-3’ containing an HindIII site. 
Following PCR amplification,  the PCR products were isolated from an agarose gel using 
the QIAquick Gel Extraction Kit (Qiagen), digested with NdeI and HindIII and cloned 
into pET28a expression vectors (Novagen). The resulting expression plasmids 
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(pET28a::TraW and pET28a::TrbC) encode for the N-terminally six-histidine tagged 
His6-TrbC and His6-TraW. 
 
3.2.2 TrbC In-Gel Trypsin Digestion for Mass Spectrometry Analysis  
Identification of TrbC dimerization was performed using an in-gel tryptic 
digestion kit (Thermo Scientific-Pierce) as per the manufacturers protocol and mass 
spectrometric analysis.  A 12% SDS gel was prepared and analyzed for the TrbC 
fractions.  The protein band of interest with a size of ~45 kDa was then excized from the 
gel.  The gel slices were destained to remove the Coomassie dye using a methanol/acetic 
acid solution, then incubated in 30 µL reduction buffer to reduce any bonds, incubated in 
30 µL of alkyl buffer and washed twice with 200 µL of the destain solution at 37 °C.  
Incubation in 50 µL acetonitrile shrunk the gel slices, which were then dried in a speed 
vac prior to the addition of 35 µL of digestion buffer, containing trypsin for over 16 hrs at 
30 °C.  This extract solution containing the peptide fractions was then sent for analysis 
using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) analysis at 
the Center for Research in Mass-Spectrometry at York University, and peptide fragments 
were analyzed using ProteinProspector (Chalkley et al., 2005). 
 
3.2.3 Expression of TraW and TrbC  
 Protein expression of pET vector-based constructs (pET28a::TraW (His6-TraW), 
pET28a::TrbC (His6-TrbC), pT7-7::TraW (TraW-His7), pT7-7::TrbC (TrbC-His7)), was 
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achieved using Escherichia coli BL21 (DE3) cells (Stratagene). Cells were grown with 
shaking in 1 L Luria-Bertani (LB) broth supplemented with 50 µg mL-1 Kanamycin 
(Kan) for pET28a expression vectors) or Ampicillin (Amp) for pT7-7 expression vectors 
at 37°C / 200 rpm until mid-log phase (OD600 = 0.7-0.9), at which point protein 
expression was induced by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) 
to a final concentration of 1.0 mM. Protein expression was allowed to continue post-
induction for additional 4 hours at 37°C, at which time cells were harvested by 
centrifugation at 6,000 x g for 20 min at 4°C.  The cells were kept frozen at -20°C until 
further use.  
 
3.2.4 Expression of MBP-TrbC 
The pMALp2::TrbC plasmid was originally provided by Dr. Laura Frost 
(University of Alberta).  This plasmid, harboring MBP-TrbC was transformed into DH5α 
cells using the heat shock transformation protocol (Invitrogen).  The DNA was then 
isolated and purified from the cells using QIAprep Spin Miniprep Kit (Qiagen).  This 
DNA was then transformed into competent ER2508 (New England Biolabs) for the 
periplasmic expression of MBP-TrbC.  Cells were grown in 1 L LB broth supplemented 
with 50 µg mL-1 Amp at 37°C / 200 rpm to mid-log phase (OD600 = 0.7-0.9).  Protein 
expression was induced with the addition of 1 mM IPTG and was allowed to proceed for 
3 hr at 37°C, and cells were harvested by centrifugation at 6,000 x g for 20 min / 4°C. 
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3.2.5 Purification of MBP-TrbC 
The MBP-TrbC protein was isolated from E. coli cells using an osmotic shock 
protocol.  The cells are washed with a hypotonic solution, [30 mM Tris, 20% sucrose, 1 
mM EDTA, pH 8.0] at a ratio of 1:10 wash solution to expression culture (v/v) while 
incubated for 10 minutes at room temperature.  The cells were centrifuged (8000 x g, 
4°C, 20 min), then the wash solution was discarded while the pelleted cells were 
resuspended in a hypertonic solution [5 mM MgSO4] at 4°C for 30 minutes, causing the 
release of the periplasmic content with MBP-TrbC.  After centrifugation (15,000 x g, 
4°C, 20 min), the supernatant with the periplasmic contents was filtered using 0.45 µm 
syringe filter to remove any cellular debris prior to purification with amylose resin 
(NEB).   
The protein is purified using a gravity flow amylose column initially equilibrated 
with the loading buffer [10 mM Tris, 50 mM NaCl, 1 mM EDTA, pH 7.4]. Since MBP 
has a higher affinity for maltose than amylose, upon the addition of an elution buffer with 
maltose the protein is displaced from the column.  Prior to elution, the column was 
washed with five column volumes (CV) of loading buffer to remove unbound 
components, then the protein was eluted with a 100% step gradient of elution buffer [10 
mM Tris, 50 mM NaCl, 1mM EDTA, 10 mM maltose, pH 7.4] over two CV.  Fractions 
collected were analyzed by measuring the absorbance at 280 nm, and were further 
analyzed by SDS-PAGE.  In cases where the removal of the MBP tag was required, this 
was acheived by incubating 25 µg Factor Xa (GE Healthcare) with ~20mg fusion protein 
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at 4°C for 48 hours, followed by the purification of the protein with the amylose resin 
again.   
 
3.2.6 Interaction of His6-TraW with His6-TrbC and Untagged TrbC 
Frozen cell pellet was resuspended on ice in lysis/loading buffer [10 mM 
imidazole, 30 mM Tris-HCl pH 8.2, 500 mM NaCl] and sonicated for 30 min of 15 s on 
cycle pulses at 30% amplitude with 30 s cooling time between each pulse.   Soluble 
cellular lysates containing His6-TraW (23.98 kDa) or His6-TrbC (23.52 kDa) were 
collected by centrifugation at 45,000 x g for 45 min at 4 °C, after which they were mixed 
and purified on a 10 mL Ni2+ charged Ni-NTA resin (Thermo Scientific) column 
equilibrated with the loading buffer.  Proteins were eluted using a step-gradient 
containing 60% elution buffer [30 mM Tris-HCl pH 8.2, 500 mM NaCl, 500 mM 
imidazole].  For the removal of the six-histidine tag (His6) of TrbC (21.64 kDa) and 
TraW (22.17 Da), His6-tagged proteins were incubated for 16 hrs at 21°C for TrbC, 
and/or 2 hrs at 37°C for TraW with 10 units/mg of thrombin (Sigma); to prevent TraW 
from degrading it was incubated at 37° for two hours.  The protein sample was analyzed 
by size exclusion chromatography (SEC) on a HiPrep 16/60 Sephacryl S-100 HR column 
(GE Healthcare; separation range 1-100 kDa) at a flow rate of 0.5 mL/min to remove 
residual thrombin and the cleaved tag using the interaction buffer [20 mM HEPES pH 
7.5, 150 mM NaCl].  The column was standardized with Blue Dextran 2000 (Vo = 36.2 
mL), 2 mg/mL BSA (MW = 66.5 kDa; Ve = 44.7 mL) and 150 mM NaCl (Vt = 106.2 
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mL).  To observe interactions between histidine-tagged and untagged TrbC with TraW, 
the three protein constructs were incubated for 2-16 hrs following which the protein 
mixtures were subjected to SEC with the interaction buffer at a flow rate of 0.5 mL/min. 
 
3.2.7 Interaction of TraW-His7 with TrbC-His7 
C-terminally tagged TraW (TraW-His7, 22.93 kDa) and TrbC (TrbC-His7, 22.53 
kDa), were expressed and purified separately, and the soluble cell lysates were loaded 
onto a Ni-NTA column. Proteins were eluted from the column with 100% of elution 
buffer (the same as for the 6-His tagged proteins).  Following separate purifications, the 
proteins were mixed and analyzed by SEC (as per section 3.2.6) using interaction buffer 
at a flow rate of 0.5 mL/min and SDS-PAGE. 
 
3.2.8 Interaction of MBP-TrbC with TraW-His7   
Soluble periplasmic solution containing MBP-TrbC was combined with a 
cytosolic solution containing TraW-His7 and loaded into Ni-NTA resin for co-
purification using binding buffer [5% (v/v) glycerol, 10 mM imidazole, 20 mM MgCl2, 
20 mM HEPES pH 8.2, 300 mM NaCl].  Proteins were eluted using a step-gradient 
containing 25% elution buffer [5% (v/v) glycerol, 20 mM MgCl2, 20 mM HEPES pH 8.2, 
300 mM NaCl, 500 mM imidazole] and analyzed by SDS-PAGE. 
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3.2.9 Immunoblot Analysis   
Proteins were separated on a 12.5% SDS-PAGE gel and transferred to 
nitrocellulose membrane (Bio-Rad) for 1 h at 120 V, following which the membranes 
then blocked with a 1% gelatin solution containing 0.05% Tween-20 overnight at 4°C.  
Histidine-tagged proteins were detected using standard procedures employing a primary 
mouse anti-His antibody (ZYMED Laboratories) at 1:10,000 dilution, and secondary goat 
anti-mouse alkaline phosphatase (AP)-conjugated secondary antibody (Sigma) at 
1:30,000 dilution.  To visualize the proteins of interest (via the AP-conjugated 2° 
antibody), the blots were incubated in a solution of 5-bromo-4-chloro-3-indolyl 
phosphate (BCIP) and nitroblue tetrazolium (NBT).  AP dephosphorylates BCIP, yielding 
bromochloro indoxyl intermediate, which is then oxidized by NBT to produce an indigoid 
dye.  In addition, NBT is also reduced by the indoxyl producing insoluble blue 
precipitate.  The combination of both coloured precipitates make the proteins visible in 
the western blot. 
 
3.3 Results and Discussion 
Previous sequencing studies have shown trbC directly upstream of traW result in 
two different polypeptides in the F plasmid (Frost et al., 1994).  These two genes, while 
expressed as two proteins in some systems, in others they are expressed as a single 
polypeptide with TrbC fused to the N-terminus of TraW (Figure 3.4) (Lawley et al., 
2003). These data suggest that TrbC and TraW share a coupled function and interact 
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during T4SS assembly. However, to date no direct evidence has been reported to support 
the hypothesis that TrbC and TraW do indeed interact; we therefore endeavoured to 
characterize the interaction using size exclusion chromatography (SEC) and pull-down 
affinity interaction analysis.   
 
3.3.1 SEC Elution profiles of TrbC 
The TrbC protein (21.64 kDa) exists in a mixture of oligomeric states in solution, 
resulting in different elution volumes when analyzed by SEC (Figure 3.6).  The larger 
oligomers elute from the column in a peak close to the void volume of the column at 40.4 
mL (Peak 1, Figure 3.6a), whereas a TrbC dimer elutes after 48.9 mL (Peak 2) followed 
by minimal amounts of the monomer 68.3 mL (Peak 3).  Similar results are observed for 
TrbC with or without histidine tags, indicating that the tag does not influence the tertiary 
structure of the protein (Figure 3.6c).  Interestingly, the higher molecular weight 
oligomers are observed both in the SEC elution profile, but also when the peaks are 
analyzed by SDS-PAGE, indicating that stable TrbC dimers/oligomers form through 
reduction-stable covalent bonds (i.e. not disulfide linkages) (Figure 3.6b,d). 
Similar to His6-TrbC, the higher oligomeric forms of the protein following the 
removal of the His-tag elute in Peak 1 (lanes 3-5, Figure 3.6d), followed by a TrbC dimer 
in Peak 2 (lanes 6-9, Figure 3.6d). The SEC elution profile of TrbC due to the different 
oligomeric forms of the protein present in solution was observed to be the same for the 
protein with an N-terminal His-tag (His6-TrbC; 23.52 kDa), C-terminal His-tag (TrbC-
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His7; 22.53 kDa), or with no tag (TrbC; 21.64 kDa) (Figure 3.6).  These results, coupled 
with the other elution profiles of the protein, suggest that the presence of the higher 
molecular weight oligomers of TrbC are not as result of a tag-induced oligomerization of 
the protein.  Table 3.1 summarizes the TraW and TrbC constructs used in this study, of 
which most constructs have similar molecular weights; the full sequences of the protein 
constructs can be found in Appendix B. 
 
 3.3.2 Identification of Dimerization of TrbC by Mass Spectrometry  
To confirm the oligomerization of TrbC and identify the protein bands of the 
higher mass, always present in SDS gels with purified TrbC, in-gel trypsin digestion was 
performed.  The protein bands from the gel were sliced and processed for analysis with 
MALDI-TOF MS method.  The identity of the band at ~45 kDa was confirmed to result 
from the dimerization of TrbC (Figure 3.7). 
 
3.3.3 Elution Profile of TraW from SEC 
Under similar experimental conditions, His6-TraW (23.99 kDa) elutes from the 
column in a single peak at an elution volume of 63.2 mL (Figure 3.8), which is indicative 
of a globular protein according to its molecular weight.  Considering the similar size of 
His6-TraW, (23.99 kDa), and that of His6-TrbC (23.52 kDa), under normal and 
monomeric conditions, monomeric TrbC would be expected to elute from the column in 
Peak 3 (Figure 3.6a) under identical experimental conditions.  Similar elution profiles 
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Figure 3.6.  TrbC exists as multiple species in solution. (A) SEC analysis of purified 
His6-TrbC at 4 mg/mL shows the presence of at least 3 oligomeric states of TrbC which 
elute in three peaks. (B) SDS-PAGE analysis of the SEC separated His6-TrbC shows the 
presence of different oligomers of the protein in the corresponding elution fractions from 
the column. Lane 1, Ni-NTA isolated His6-TrbC; lane 2-4, Peak 1; lanes 5-7, Peak 2; 
lanes 8-9, Peak 3. In-gel trypsin digestion followed by mass spectrometric analysis of the 
contents of the higher molecular weight bands in lanes 1-4 (highlighted with red boxes) 
confirm that these species are indeed higher order oligomers of TrbC. (C) SEC analysis 
of TrbC following removal of the N-terminal His6 tag results in a greater amount of TrbC 
oligomerization in solution, with a marked increase in the relative peak height of Peak 2 
and decrease in Peak 3. (D) SDS-PAGE analysis of the SEC separated TrbC. Lane 1 Ni-
NTA isolated TrbC (prior to removal of the His tag); lanes 2-4, Peak 1; lanes 5-8, Peak 2 
and lane 9, Peak 3. 
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Table 3.1.  The TrbC and TraW constructs used in this study* 
 
Protein Construct Molecular Weight (kDa) 
TrbC 21.64 
TrbC-His7 22.53 
His6-TrbC 23.52 
MBP-TrbC 66.93 
TraW 22.17 
TraW-His7 22.93 
His6-TraW 23.99 
 
 
*Purification tags are 6 or 7 histidine residues or Maltose binding protein (MBP).  The 
tag on the right denotes C terminally tagged, the tag on the left denotes N-terminally 
tagged. 
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Match to: gi|9507801 Score: 151 
conjugal transfer pilus assembly protein TrbC [Plasmid F] 
Nominal mass (Mr): 23532; Calculated pI value: 8.87 
Matched peptides shown in Bold Red 
 
     1 MKLSMKSLAA LLMMLNGAVM ASENVNTPEN RQFLKQQENL SRQLREKPDH  
    51 QLKAWAEKQV LENPLQRSDN HFLDELVRKQ QASQDGKPRQ GALYFVSFSI  
   101 PEEGLKRMLG ETRHFGIPAT LRGMVNNDLK TTAEAVLSLV KDGATDGVQI  
   151 DPTLFSQYGI RTVPALVVFC SQGYDIIRGN LRVGQALEKV AATGDCRQVA  
   201 HDLLAGKGDS GK 
 
 Start - End   Observed  Mr(expt) Mr(calc)   Delta   Miss Sequence 
    68 - 78     1344.70  1343.69  1343.65     0.05     0  R.SDNHFLDELVR.K (Ions score 52) 
    90 - 107    2041.00  2039.99  2040.07    -0.08     1  R.QGALYFVSFSIPEEGLKR.M(Ions 
score 50) 
   114 - 122    1011.60  1010.59  1010.57     0.03     0  R.HFGIPATLR.G  (Ions score 29) 
   142 - 161    2153.10  2152.09  2152.04     0.05     0  K.DGATDGVQIDPTLFSQYGIR.T(Ions 
score 20) 
 
 
 
 
Figure 3.7.  MALDI‐TOF MS analysis for tryptic‐digested SDS‐PAGE band appearing at ~45 kDa which results due to the dimerization of the protein monomer TrbC ~23 kDa, even under the conditions of a denaturing SDS gel analysis. 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were observed for TraW without or with both N-terminal or C-terminal His-tags, eluting 
in a single peak (Ve = 63 mL).  It should be noted that TraW precipitates when stored at 
4°C, yet degrades when stored at room temperature (21°C). 
 
3.3.4 Interaction Studies of TraW-His7 and TrbC-His7 using SEC 
C-terminally tagged TraW and TrbC (TraW-His7 and TrbC-His7) were purified 
separately prior to 3-4 hour incubation, concentration, followed by analysis using SEC.  
A shift in the elution profile of the proteins was observed (Figure 3.9a).  Similar to the 
SEC elution of TrbC alone, three peaks were observed; TrbC is found primarily in Peaks 
1 and 2 while TraW is observed to co-elute with TrbC in Peak 2 and elutes as a monomer 
protein in Peak 3 (Figure 3.9c).  Considering the elution profile of TraW alone (Figure 
3.8) where the protein elutes in a single peak at 63.2 mL, its elution in Peak 2 at 54.1 mL 
(Figure 3.9) can be associated with a larger molecular size as a result of its interaction 
with TrbC-His7 .  SDS-PAGE analysis of the contents of Peak 2 show that both TrbC and 
TraW are present (Figure 3.9b; lanes 5-7). 
 
3.3.5 Pull-down Affinity Used for Probing Interaction of MBP-TrbC and 
TraW-His7 
TraW-TrbC interaction was confirmed with an affinity capture assay using TraW-
His7 as a bait.  TraW-His7 was isolated from cell lysate on a Ni-NTA column, following 
which a periplasmic cell lysate containing MBP-TrbC (66.93 kDa) was added.  
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Figure 3.8.  SEC analysis of His6-TraW.  Unlike TrbC, TraW (4 mg/mL) elutes in a 
single peak at an elution volume of 63.2 mL, corresponding to a monomeric species in 
solution. SDS-PAGE analysis of the contents of the single elution peak (inset) confirm 
the presence of a 23.99 kDa TraW monomer. 
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Figure 3.9. Interaction of C-terminally His-tagged TraW and TrbC. (A) SEC analysis 
of a TraW-His7 (3 mg/mL) and TrbC-His7 (3 mg/mL) mixture. The three observed peaks 
are indicative of multiple species being present in solution, and the contents of the peaks 
were confirmed by SDS-PAGE.  (B) SDS-PAGE analysis of the SEC-separated TraW-
TrbC peaks (graph A). Lanes 2-4 are from Peak 1, lanes 5-7 are from Peak 2 and lanes 8-
9 are from Peak 3.  The differences in molecular weight between TraW-His7 and TrbC-
His7 allow for identification of the protein contents of each peak.  Accordingly, peak 1 is 
composed primarily of TrbC oligomers (as determined by MS analysis), peak 2 is a 
TraW-TrbC dimer and peak 3 is primarily composed of TraW. 
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After a subsequent wash step for the removal of unbound proteins, TrbC-His7 was eluted 
from the column with 125 mM imidazole, and the peak elution contents analyzed by 
SDS-PAGE. In aliquots corresponding to the imidazole eluted peak, a high molecular 
weight MBP-TrbC band is observed in addition to the expected TraW-His7 band (Figure 
3.10a).  A negative control experiment was done to rule out the possibility of MBP-TrbC 
binding to the Ni2+ charged resin (Figure 3.10b). 
It is interesting to note that this observation both confirms the SEC observations, 
and provides an insight into the orientation of the preferred TraW-TrbC interaction.  
Sequence alignment predictions (Figure 3.4) and gene expression (Frost et al., 1994) 
suggested that the C-trminal domain of TrbC interacts with the N-terminal of TraW.  The 
presence of the large N-terminal MBP tag on TrbC and proximal location of the Ni-NTA 
resin to small C-terminal His6 tag of TraW indicates that the TraW-TrbC interaction 
likely occurs between the C-terminal region of TrbC and N-terminal region of TraW. 
Steric bulk of the TrbC tag and Ni-NTA resin to which TraW is immobilized precludes 
any other orientation by which the two proteins could interact.  
It is important to mention the unstable nature of TrbC, which has been found to 
degrade in a short period of time when purified.  In addition, the low expression levels of 
the protein using a periplasmic system with the MBP tag imposed a challenge.  However, 
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Figure 3.10.  SDS-PAGE analysis of an on-column capture of MBP-TrbC by TraW-His7.  
(A) TraW-His7 was bound to Ni-NTA resin, following which MBP-TraW containing cell 
lysate (Lane 1) was added to the column; Lane 2, flow through; lane 3, wash; Lanes 4-9, 
the TrbC-TraW complex eluted with 125 mM imidazole. (B) Negative control SDS-
PAGE gel, Lanes 2-3, flow through; lanes 4-5, wash of unbound; lanes, 6-7, elution with 
50 mM imidazole; lanes 8-9, elution with 125 mM imidazole. The presence of the N-
terminal MBP tag on TrbC and proximal location of the Ni-NTA resin to the C-terminus 
of TraW may suggest that the TraW-TrbC interaction occurs between the C-terminal 
region of TrbC and N-terminal region of TraW. 
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despite these challenges, it can be seen that the interaction of TraW with TrbC also has a 
stabilizing effect on TrbC, as suggested by the amount of MBP tag cleaved in the 
negative control gel, without the presence of TraW (Figure 3.10). 
 
3.3.6 Preferred Interaction of TraW with the Free N terminal end of TrbC 
While our results show the proteins interacting in SEC, based on their elution 
profiles with the same tags, and also in Ni-NTA with different affinity tags, we aimed to 
confirm if there is a preference between the interaction of TraW with the C or the N 
terminal domain of TrbC.  The F plasmid map reported by Frost et al. (1994), shows that 
the traW gene is encoded before trbC.  On the other hand,  when the two proteins are 
fused into one gene (Figure 3.4), the TrbC sequence is encoded before TraW (Lawley et 
al., 2003).  This indicates a higher probability of TraW interacting with the C-terminal 
end of TrbC in cases when the proteins are expressed separately, as in the F plasmid.  
Additionally, in the UWE25 plasmid, (Protochlamydia amoebophila) where the proteins 
are encoded separately, traW is followed by trbC, without traU separating the two as 
seen in the F plasmid (Greub et al., 2004).   
When the three different proteins His6-TraW (23.99 kDa), His6-TrbC (23.52 kDa), 
and TrbC (21.64 kDa) are co-eluted and separated by SEC, a preference for interaction 
between His6-TraW with untagged TrbC is observed. (Figure 3.11).  His6-TrbC and 
untagged TrbC proteins behave similarily when analyzed individually by SEC in the 
presence of TraW.  However, His6-TraW co-elutes from the mixture with untagged TrbC 
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in Peak 2 at 50.0 mL elution volume (Figure 3.11a) and not His6-TrbC (Figure 3.11b, 
lanes 5 & 6).  This suggests that TrbC is preferentially interacting with TraW, and that N-
terminally tagged TrbC has a lower potential to interact with TraW due to its histidine 
tag.  This also could suggest that the interaction between TrbC and TraW is stronger than 
that between TrbC homodimer. 
To confirm the identity of the tagged proteins a Western Blot was done in parallel 
with a 12.5% SDS-PAGE using anti-His primary antibody to detect His6-TraW and His6-
TrbC (Figure 3.11b).    Monomeric His6-TrbC was observed in lanes 9 and 10, which 
were collected in Peak 3 (Ve = 63.7 mL).  His6-TraW (detected on the transfer blot) with 
TrbC (not detected on the blot, but present from the SDS-PAGE) is observed in lanes 5 
and 6 (Figure 3.11b) due to the co-elution of the proteins from the SEC column (Figure 
3.11a; Peak 2).  
To put all this into perspective, Figure 3.12 shows the overlay (bottom panel) of 
the different elution profiles (top panels).  Monomeric His6-TraW (brown) elutes at Ve = 
63 mL.  Untagged TrbC (Blue) elutes at  Ve = 39 mL as a tetramer (86.56 kDa) and at Ve 
= 50 mL as a dimer (43.28 kDa).  When TraW is incubated with His6-TrbC and untagged 
TrbC (red), they co-elute in Peak 2 at Ve = 50 mL, due to the interaction between TraW 
with untagged TrbC (total MW = 45.63 kDa). 
 
  113 
3.3.7 Interactions of TrbC with Untagged TraW  
Similar experiments using N-terminally tagged constructs of His6-TrbC (23.52 
kDa) and His6-TraW (23.99 kDa) were analyzed with SEC to show interaction between 
TrbC and TraW.  The removal of the His-tag from TraW (22.17 kDa) was never 
desirable, since the tag was never completely cleaved when incubated over 16-20 hrs at 
21°C with thrombin, while longer incubation times would cause protein degradation.  
After purifying both proteins separately with Ni-NTA resin, cleaving His6-tag from 
TraW, followed by  the removal of thrombin with a SEC for TraW only, the cleaved 
TraW and His6-TrbC were incubated prior to loading into SEC jointly.  The results also 
confirm the interaction between TraW and His6-TrbC (Figure 3.13).  TraW is found in 
Peak 1 as well as Peak 2, but not in Peak 3 where the homogeneous monomeric TraW 
elutes.  On the other hand, His6-TrbC is found mainly in Peak 3, while the rest is in Peak 
1 with TraW, as indicated by the gel lanes 2 and 3 (Figure 3.13a,b).  It is not clear 
whether TrbC is found in Peak 2, since all what is visible from the gel is TraW and 
residual His6-TraW.  The presence of TraW in Peak 1 with His6-TrbC confirms the 
protein-protein interaction; this analysis was conducted in triplicate, with similar results. 
These observations presented here clearly indicate an interaction between TrbC 
and TraW of the F-plasmid T4SS.  While there is an interaction between different His-
tagged proteins on either terminal end, there is preferential interaction of TraW and the 
untagged N-terminal end of TrbC.  Our findings suggest that during the F pilus assembly, 
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Figure 3.11.  Interaction of N-terminally His-tagged TraW and TrbC in the presence of 
His-tagged TrbC. SEC elution profile of a His6-TraW/His6-TrbC/TrbC mixture lined up 
in decreasing size order. (A) SEC elution profile of the His6-TraW/His6-TrbC/TrbC 
mixture, again indicating multiple species in solution. (B) SDS-PAGE (left) and Western 
blot (right) analysis of SEC separated peaks. Western blot analysis was conducted using 
an anti-His6 primary antibody. Lanes 1-3 are His6-TrbC, TrbC and the His6-TraW/His6-
TrbC/TrbC mixture, respectively; lane 4 is from Peak 1 corresponding to TrbC; lanes 5-6 
from Peak 2 corresponding to His6-TraW/TrbC; lanes 7-9 from Peak 3 corresponding to 
mainly His6-TrbC. Comparison of the SDS-PAGE and Western blots shows the presence 
of distinct TraW bands in lanes 5-6 (highlighted red box), with corresponding untagged 
TrbC. This indicates that TraW preferentially interacts with untagged TrbC, with residual 
TraW then interacting with His6-TrbC (lane 7); the remaining unbound His6-TrbC elutes 
in Peak 3 (lanes 8-9) as confirmed by the anti-His antibody. 
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Figure 3.12.  Overlaying of the individual elution profiles of TrbC (blue), His6-TraW 
(brown), and all three His6-TraW, His6-TrbC and TrbC mixed in (red).  His6-TraW 
(brown) where the TraW elutes in a single peak 63 mL.  Untagged TrbC (blue) has a 
similar profile to the tagged TrbC, the protein elutes in two peaks 39 mL (tetramer) and 
50 mL (dimer).  The co-elution profile all three proteins is shown by the graph in red, 
where the elution occurs in three different peaks, 39 mL, 50 mL, and 63 ml; in this case 
however TraW co-elutes with TrbC in the second peak at 50 mL (heterodimer) while 
His6-TrbC elutes in the third peak at 63 mL (monomer).  The black arrow at 45 mL 
indicates the elution of the BSA standard with the MW = 66.5 kDa. 
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mating pair formation and bacterial conjugation the two proteins interact and have a 
common role even when they’re expressed separately.   Further characterization of this 
interaction will lead to a better understanding of F-mediated bacterial conjugation, and 
potentially leading to more effective strategies targeting microbial plasmid delivery, 
which could offer benefits for public health in addition to more effective treatments of 
bacterial infections and reduction of the spread of multidrug resistance. 
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Figure 3.13. Interaction of N-terminally His-tagged TrbC and untagged TraW, in the 
presence of residual His6-TraW. (A) SEC analysis of the protein mixture with mostly 
His6-TrbC and TraW. The three observed peaks are indicative of multiple species being 
present in solution, and the contents of the peaks was confirmed by SDS-PAGE. (B) 
SDS-PAGE analysis of the SEC-separated TraW-TrbC peaks. Lane 1, mixed proteins 
before SEC; Lanes 2-4 are from Peak 1, lanes 5-8 are from Peak 2 and lane 9 is from the 
centre of Peak 3.  Accordingly, peak 1 is composed primarily of TrbC oligomers 
including TraW and His6-TrbC, peak 2 is a TraW and residual His6-TraW and peak 3 is 
primarily composed of His6-TrbC. 
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Chapter 4 
Purification of TrbC and Crystallization of TraW from the Escherichia 
coli F Plasmid 
4.1 Introduction 
In gram-negative bacteria, construction of the secretion system pore requires 
localization of various structural and catalytically active proteins at the bacterial 
membranes and within the periplasm.  To ensure proper folding and protein assembly in 
the periplasm, bacteria produce proteins that promote disulfide bond formation, generally 
between cysteine-containing proteins (Hemmis & Schildbach, 2013).  The F plasmid of 
E. coli encodes for thirty-five different proteins, where ten of them have at least one 
cysteine residue, localized or partially associating with the periplasm (Frost et al., 1994).  
Recent data suggests that TrbC and TraW, as periplasmic proteins, both containing two 
and one cysteine residues, respectively, play an important role in the conjugative 
processes as mediators in folding and assembly of the pore complex proteins by inter- 
and intramolecular thiol redox reactions (Hemmis & Schildbach, 2013). 
As two hallmark proteins from the E. coli F plasmid, TrbC and TraW are important 
for bacterial conjugation, due to their role in the F pilus assembly (Anthony et al., 1999; 
Arutyunov et al., 2010).  Based on its amino acid sequence, TrbC is a 22.5 kDa 
hydrophilic protein with 32% hydrophobic content, which suggests peripheral membrane 
associations (Frost et al., 1994) and exists as a dimer/oligomer (Chapter 3, in particular 
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Figure 3.7).  In addition, TrbC is correctly processed in the presence of TraN, suggesting 
an interaction between these two proteins, which are encoded on adjacent genes of the F 
plasmid (Figure 3.3).  On the other hand TraW is a 210 amino-acid, 23.6 kDa protein 
(Maneewannakul et al., 1992) found to interact with TrbB (Harris & Silverman, 2004), a 
disulfide bond isomerase (Hemmis & Schildbach, 2013).  In addition, TrbC and TraW 
have thioredoxin-like signature folds, βαβαβ or ββα, as predicted by Phyre2 (Kelley & 
Sternberg, 2009) (Figure 4.1) but they lack the signature sequence C-X-X-C motif that is 
specific to thioredoxins (Martin, 1995).  Based on a 13% matched sequence identity 
(mainly attributed by the C-terminal domain of TrbC, where the two cysteine residues are 
found) with 90% confidence TrbC is predicted to be a thioredoxin-like protein.  
Similarly, TraW with 11% sequence identity and 45% confidence in predicted to be a 
thioredoxin-like protein.   
Based on the predicted redox properties of the proteins due to the two cysteine 
residues, TrbC could potentially be similar to a substrate for thiol-oxidase DsbA (Figure 
4.2a), whereas TraW (with one free cysteine) could be a substrate to a disulfide bond 
isomerase/sulfenate (–SOH) DsbG, which oxidizes free thiols (Figure 4.2b).  However, 
without evidence of partricular protein function other than being required for F plius 
formation (Frost et al, 1994; Lawley et al, 2003), efforts to crystallize TrbC and TraW 
were undertaken to provide a structural analysis of the proteins to facilitate functional 
characterization.  While challenging to obtain suitable quantities of solbule protein of 
significant puriity, initial crystals of TraW have been obtained from which optimization 
can be undertaken. 
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B. 
 
 
 
 
Figure 4.1.  Structure predictions for TrbC and TraW.  (A) Structure similarity of TrbC 
with c2iWtA protein, with an oxidoreductase fold, belonging to thioredoxin isoform 
superfamily and thioredoxin with a disulfide complex family. 3-D structure generated by 
PyMol, and 2-D topology diagram showing the signature βαβαβ thioredoxin-like fold.  
(B) Structure similarity of TraW with d1zzoa1 protein, with a thioredoxin fold, belonging 
to Thioredoxin-like superfamily, and Glutathione peroxidase-like family.  3-D structure 
generated by PyMol and 2-D topology showing the signature thioredoxin fold βαβαβαβ. 
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Figure 4.2.  Periplasmic redox systems in E. coli.  (A) Thiol-oxidase DsbA oxidizes a 
substrate in the periplasm with multiple cysteine residues that are not in close sequence 
proximity, such as TrbC.  The reduced DsbA donate electrons to the membrane bound 
DsbB, to recycle the electrons, and resume active state.  (B) Disulfide bond isomerase 
DsbC and disulfide bond sulfenate (-SOH) reductase DsbG become oxidized upon 
isomerization from DsbC, or sulfenate reduction of a substrate with a free thiol, such as in 
TraW, by DsbG.  Both proteins accept electrons from the cytoplasm via TrxA into the 
periplasm through DsbD, to resume active states.  Copied from Hemmis & Schildbach, 
2013.  
 
  122 
4.2 Materials and Methods 
4.2.1 Cloning and purification of the C-terminal domain of TrbC (TrbCC) 
Phusion® High-Fidelity DNA Polymerase (NEB) was used to amplify the C-
terminal sequence of TrbC (NP_061467.1; residues 102-212) (Frost et al., 1994) using 
pT7-7::TrbC construct as a template, with PCR primers: forward, 5’-
GCTTCCATGGGCGAAGAGGGGCTGAAACGAATG-3’ and reverse, 5’-
GCGTTCTCGAGTTTCCCGGAATCTCCTTTCCC-3’, using restriction sites NcoI and 
XhoI respectively (shown in italics).  The resulting PCR product was purified from a 1% 
agarose gel using Qiaquick Gel extraction kit (Qiagen), then double digested with NcoI-
HF and XhoI restriction enzymes.  Following a reaction cleanup with Gene Jet PCR kit 
(Fermentas), the digested PCR product (332 bp), was ligated at 16°C overnight into a 
pET28a similarily digested with NcoI and XhoI.  The resulting construct was used to 
transform into DH5α cells for storage.  DNA sequencing analysis and positive colony 
PCR reactions determined the correct cloning of TrbCC.  The final pET28a::TrbCC 
product was transformed into E. coli BL21 (DE3) cells for expression.  The TrbCC 
construct contains a C-terminal 6-His tag; purification of TrbCC-His6 proceeded under 
identical conditions as for the full length TrbC or TraW (Chapter 3).  SEC analysis 
(Figure 4.3a) indicates that TrbCC possesses the same properties as the full length protein, 
and exists as oligomers in solution, which was confirmed by SDS-PAGE (Figure 4.3b; 
Peak 1 = lanes 3-4, Peak 2 = lanes 7-9). 
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Figure 4.3.  TrbCC exists as multiple species in solution. (A) SEC analysis of purified 
TrbCC-His6 shows the presence of at least 3 oligomeric states of TrbC which elute in two 
peaks. (B) SDS-PAGE analysis of the SEC separated TrbCC-His6 shows the presence of 
different oligomers of the protein in the corresponding elution fractions from the column. 
Lane 1, Ni-NTA isolated TrbCC-His6; lane 3-5, Peak 1; lanes 6-9, Peak 2. 
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4.2.2  Expression and purification of TrbC   Full‐length  TrbC was expressed and purified following the same methods as 
discussed in Chapter 3.  Gravity flow purification or purification using automated 
methods with ÄKTApurifier 10 (GE Healthcare) resulted in similar amounts of protein of 
similar purity.  A typical purification and analysis of TrbC is shown in Figure 4.4. 
Various additives were used during the purification of TrbC in an effort to 
increase the solubility and reduce aggregation of the protein.  Additives included 0.05-
0.2% NP-40, 0.05%-1% Triton X-100, 1-3 mM Dithiolthreitol (DTT), 1-5 mM Tris(2-
Carboxyethyl)-phosphine Hydrochloride (TCEP HCl), 4 mM Glutathione (GSH), 5-15% 
glycerol as well as 1-2 % n-octyl-β-D-glucopyranoside (OG). 
 
4.2.3  Expression and purification of TraW 
Expression of full-length TraW was carried out as described in Chapter 3.  To 
purify TraW for crystallization the frozen cell pellet was resuspended in 1:10 (w/v) 
lysis/loading buffer [500 mM NaCl, 30 mM Tris, 10 mM imidazole, pH 8.2].  The 
resuspended cells were lysed by sonication (Sonic Dismembrator 500, Fisher Scientific) 
while cooling on ice for 5 min (10s on/15s off).  The insoluble cell lysate was removed 
by centrifugation at 34,000 x g for 30 min at 10 °C.  The supernatant was loaded onto a 
pre-equilibrated 12 mL Ni2+ charged Ni-NTA resin (Thermo Scientific) and the column 
was subsequently washed with at least 5 column volumes (CV) of the loading buffer to 
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Figure 4.4.  TrbC-His7 purification using Ni-NTA affinity chromatography.  (A) 
Chromatogram showing the elution of the protein during a linear gradient from 10-
500mM imidazole, where the protein elutes during peak 1, with 125-150 mM imidazole. 
(B) The corresponding SDS-PAGE results.  Lane 1, cell lysate; lane 2 flow through; lanes 
4-8 protein elution from the column with the addition of 125-150 mM imidazole. (C) The 
final protein product after purification with SEC, lane 1; and concentrated to 4 mg/mL. 
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remove any contaminants.  The protein was purified from the column using a step 
gradient with elution buffer [500 mM NaCl, 500 mM imidazole, 30 mM Tris, pH 8.2].   
After washing the column with 5 CV of loading buffer, followed by 5 CV of 10 % elution 
buffer. The bound protein was eluted over 5 CV with 60 % elution buffer (300 mM 
imidazole) at a gravity flow rate of 0.5 mL/min.  The fractions containing TraW were 
incubated with 10 U/mg thrombin overnight at 21°C for the cleavage of the His tag.  The 
protein solution was concentrated using a 10 kDa MWCO centrifugal concentrator 
(Millipore) at 4,000 x g and 14°C to a final volume of 5 mL.  TraW was further purified 
using SEC on a HiPrep 16/60 Sephacryl S-100 HR column (GE Healthcare) for buffer 
exchange [200 mM NaCl, 20 mM Tris, pH 7.0] and the removal of the His tag.  The 
isolation of the protein in this manner yields TraW in over 90 % purity (Figure 4.5), as 
monitored by SDS-PAGE.  Fractions corresponding to TraW without the His tag were 
collected and concentrated to 5-8 mg/mL prior to crystallization. 
 
4.2.4 Crystallization of TraW 
Initial crystallization experiments were performed by screening conditions in 
commercially available kits: Classics Suite, JCSG I, JCSG II, JCSG III, JCSG IV, and 
JCSG + from Qiagen (Lesley & Wilson, 2005).  The trials were set in 96-well sitting drop 
plates (Axygen) by hand with 1 µL protein solution concentrated to ~8 mg/mL, and 
mother liquor in a 1:1 ratio over a reservoir containing 150 µL mother liquor.  The crystal 
trays were stored at 21 °C and 4°C.  Crystal hits formed were found only in one condition  
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Figure 4.5.  TraW purification using SEC gel filtration, after purification with Ni-NTA 
and thrombin cleavage of the His tag. (A) Chromatogram showing purification of the 
protein, peak 1, high molecular mass impurities, whereas the ~90% pure TraW elutes 
during peak 2. The shoulder on the left of peak 2 is a result of the mixed cleaved and 
uncleaved His tag (B) The corresponding 12% SDS-PAGE gel.  Lane 1, concentrated 
TraW after isolation with Ni-NTA; Lane 2, contents of peak 1 from the chromatogram; 
lane 3-4, peaks corresponding to the shoulder on the left of peak 1; lanes 5-9, fractions 
corresponding to peak 1, where untagged TraW elutes from the column. 
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from JCSG II condition # 20 [0.2 M Magnesium chloride, 0.1 M imidazole pH 8.0, 40% 
(v/v) MPD] and only at 4°C.  Optimization of the crystallization conditions was 
attempted by varying the precipitant concentration and the pH, while using hanging drop 
24 well plates with cover slips (VWR), in addition to varying the ratio of protein to the 
mother liquor on the drop equilibrated against 0.5 mL of reservoir; the Additive Screen 
(Hampton Research) was also used for optimization; however, the attempts to get larger 
and more stable crystals were unsuccessful.  Very thin and 15-50 µm long crystals 
appeared, which would dissolve in 2-3 days; while reproducible, the crystals did not 
improve upon optimization.  The same crystals were obtained using TraW with the C-
terminal 7-His tag (TraW-His7). 
 
4.2.5 Circular Dichroism Spectroscopy (CD) of TraW 
 To determine the effect of n-octyl-β-D-glucopyranoside (OG) on TraW, CD 
spectra (200-260 nm) were acquired using a Jasco J-810 CD spectrometer, with a 0.1 cm 
path length cuvette at 22°C.  The protein was prepared using Ni-NTA, followed by SEC 
with [150 mM NaCl, 30 mM Tris, 10% (v/v) glycerol, pH 7.6] and concentrated to 5 
mg/mL.  Spectra were obtained of the protein alone, and in the presence of 1% (w/v) OG 
to compare the protein in the presence or absence of the detergent.  Spectra were obtained 
in duplicate and the scans were corrected for the buffer contribution through the use of a 
buffer-only spectra. 
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4.3 Results and Discussion 
4.3.1 TrbC Thioredoxin-Like Properties 
 With the high probability that TrbC is a thioredoxin-like protein, purification and 
crystallization of the protein under various reducing conditions was attempted in an effort 
to obtain soluble, homogeneous, and therefore crystallizable protein (McPherson, 1999).  
Under non-reducing conditions the protein exists as a mixture of monomer and oligomers 
(Chapter 3), making crystallization incredibly challenging.  During purification with Ni-
NTA and in the presence of high concentrations of imidazole, the protein was found to 
reduce the Ni2+ in the column, as indicated visually by the change in colour of the resin 
from green to yellow, suggesting redox properties of the protein.  Different reducing 
agents were utilized when purifying the protein; while they helped with increasing the 
protein solubility, they were not effective in that they induced degradation of the protein 
(Figure 4.6a).  Similar observations were noted with BME, DTT, as well as TCEP; which 
is more effective and more commonly used for crystallization because of its stability as a 
reducing agent (Han & Han, 1994).  On the other hand purification under the same 
conditions with SEC and buffer [150 mM NaCl, 30 mM Tris-HCl, pH 8.0] and addition 
of 4 mM GSH proved to be more effective.  While GSH does not increase the solubility 
of the protein it reduces its oligomerization, and increases the homogeneity of the sample 
(Figure 4.6b).   
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Figure 4.6.  The affect of different reducing agents on TrbC.  (A) TrbC after purification 
with SEC and [150 mM NaCl, 30 mM Tris-HCl, pH 8.0, + 5 mM BME]; the protein 
becomes more soluble but denaturation is increased. (B) TrbC after purification by SEC 
in the presence of 4 mM GSH.  While the solubility of the protein is not affected, the 
stability of the portein is increased.    
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Although crystallization trials of TrbC in the presence of GSH as an effective 
reducing agent were undertaken, protein crystals were not observed.  Given the properties 
of thioredoxin-like proteins, which can take months to crystallize while the protein slowly 
oxidizes (Weichsel et al., 1996), coupled with the unstable nature of TrbC, we were not 
able to obtain TrbC protein crystals suitable for X-ray diffraction analysis. 
While the full-length TrbC was difficult to work with, constructs of the N-
terminal domain and the C-terminal domain of the protein were cloned.  The N-terminal 
domain construct was not a successful target as the protein would not express in E. coli 
(BL21) cells.  On the other hand the C-terminal domain, TrbCC, did not express well, 
however it has the same properties as the full-length protein (Figure 4.3) and it 
oligomerizes; crystallization of this construct was also attempted.  Taking into account 
that both cysteine residues reside in the C-terminal domain of the protein (see Appendix 
B), it is possible that this region of the protein is responsible for the thioredoxin-like 
properties of TrbC. 
 
4.3.2 Crystallization of TraW 
 With one free thiol, as a result of a single cysteine residue in its sequence, TraW 
was not as difficult to express and purify.  Crystallization of the protein, on the other 
hand is a challenge.  TraW is found to aggregate and precipitate at 4°C, whereas at room 
temperature at 21°C the protein degrades.  This could due to the protein’s thermal  
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Figure 4.7.  Crystallization of TraW at 4°C.  (A) Small crystals with 15-50 µm length 
formed in 2-3 days. (B) SDS-PAGE gel of purified TraW (22.17 kDa). Lane 1, the 
protein in [200 mM NaCl, 20 mM Tris, pH 7.0], concentrated to 8 mg/mL for 
crystallization trials; lane 2, the same sample after 1 week incubation at 4°C. 
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Figure 4.8.  Evolving TraW crystals. (A) Microcrystals in areas indicated by the red 
arrows (B) Crystals of the same drop turned to precipitate over time as shown in areas 
indicated by the red arrows. 
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instability in the absence of intramolecular disulfide bonds (Wang et al., 2004; Trivedi et 
al., 2009).  The precipitation of the protein at 4°C was reversible, however not preferred 
since protein degradation still occurs.  For this reason the protein was handled at 14 °C, a 
temperature that was determined to be less problematic at least over a short period of 
time.  Tiny 15-50 µm TraW protein crystals formed in 2-3 days only at 4°C (Figure 4.7a). 
The protein sample used for crystallization was over 90% homogeneous, however when 
incubated for a 7 days at the same temperature as the crystallization plates, at 4°, the 
protein was found to degrade (Figure 4.7b).  The same phenomenon was observed in the 
crystals as well (Figure 4.8).  With continuous monitoring it was found that the protein 
crystals turned into an amorphous precipitate as shown in Figure 4.8b, indicating protein 
precipitation due to instability (McPherson, 1999). 
 While various additive agents were added in an attempt to increase the stability of 
the protein, OG detergent was found to have a positive effect.  In the presence of 1% 
(w/v) detergent TraW was less autolytic.  This effect of the detergent was also 
investigated using CD spectroscopy (Figure 4.9).  The CD spectra do not show 
appreciable difference between the two protein solutions, however, there is a small 
reduction of the minima at 222 nm indicating a slight loss of α-helical structure of the 
protein (Wallace & Janes, 2009).  Although the detergent appears to be an effective agent 
for stabilizing the protein, in its presence or without the same crystals formed and 
disappeared.
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Figure 4.9.  The effect of OG on TraW.  (A) Protein purified in the absence (lane 1) and 
the presence of 1% (w/v) OG (lane 2).  (B) CD spectroscopy scan showing overall similar 
protein folding, with the exception of the reduced minima at 222 nm. 
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The observations presented here indicate that while TraW is difficult to express 
and purify the protein is crystallizable.  Further optimization of the purification and 
crystallization conditions could lead to TraW crystals suitable for structure and function 
determination using X-ray crystallography. 
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Chapter 5 
Concluding Remarks and Future Work 
 
5.1 LytR from TCSs 
Two component systems play an important role in bacterial survival, adaptation, 
and virulence.  These systems sense environmental changes via the HK and in response to 
a variety of stimuli regulate genes expression through RRs.  S. aureus as an opportunistic 
pathogen, which is normally found in healthy human skin and mucous membranes, has 
become a threat primarily to the infected immunocompromised individuals (Zhu et al., 
2010).  This threat is magnified by the fact that the bacteria are becoming multi-drug 
resistant and as such they pose serious concerns in human health.  The enhanced 
resistance to antibiotics and to the components of the innate host defence mechanisms is 
attributed by the ability of microbes to form thick multilayered biofilms (Donlan & 
Costerton, 2002).   
 S. aureus genome contains two genes lytS and lytR that have sequence similarities 
with sensor and response regulators, respectively,  from bacteria TCSs (Brunskill & 
Bayles, 1996).  The conserved structural arrangement and their ability to regulate lrgAB 
and cidABC genes that affect murein hydrolase activity, stationary-phase survival, 
antibiotic tolerance and biofilm formation (Sharma-Kuinkel et al., 2009), indicate that 
these genes have highly conserved functions and are represented by TCSs (Brunskill & 
Bayles, 1996).  Two regulatory networks control expression of cidABC and lrgAB, one is 
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as a consequence of carbohydrate metabolism in response to acetic acid accumulation 
(Rice et al., 2005) and the other as a result of change in membrane potential (Patton et al., 
2006).  In addition TCS RRs have been found to activate upon phosphorylation by the 
HK, as well as phosphorylation by small-molecule phospho donors, such as acetyl 
phosphate (Lukat et al., 1992; McCleary, 1996).  For these reasons it has been suggested 
that the LytSR may control lrgAB transcription by two mechanisms; one via sensing of 
the membrane potential change and the other by direct phosphorylation with acetyl 
phosphate in the presence of acetate accumulation (Sharma-Kuinkel, 2009).   
In the absence of structural information of LytS and LytR from S. aureus TCS, we 
have determined the X-ray crystal structure of N-terminal domain of LytR.  While this 
information does not provide us with sufficient clues as to how LytR regulates DNA 
binding and lrgAB and cidABC gene transcription, it confirms that the protein structure 
closely resembles other known RRs.  In addition, the apo-LytRN form shows striking 
similarity to the BeF-LytRN complex (representing a phosphorylated form of the protein), 
with an overall RMSD value 0.616 Å.  In the structure of LytRN the sulfate ion occupies 
the active site, where a phosphate would be located in the active form; the active site 
residues adopt conformations similar to other phosphorylated N-terminal domains of 
RRs.  For this reason both BeF-LytRN and apo-LytRN have similar active-like structures 
as compared to other RRs.  While the overall differences between the two crystal 
structures of LytRN are small the main difference between the two structures exists in the 
extension of helix α4 in the presence of BeF3- as induced by the interaction of Thr81 with 
a fluoride of the BeF3- complex.  In addition the dimerization mode of the N-terminal 
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receiver domain resembles more closely to the same family of RR such as ComE from 
the same LytR subfamily (Boudes, et al., 2014), which involves the loop region between 
helix-α4 and sheet-β5, not seen in other family of RRs.  Our findings suggest a conserved 
mode of dimerization amongst same family members.   
Phosphorylation-induced dimerization is known to enhance DNA binding 500-fold 
(Koenig et al., 2004).  A proposed model based on the structure of AgrAC (LytTR, C-
terminal domain) bound to DNA (which consists of two direct repeats separated by 12 
bp), suggests that only the dimeric N-terminal domain must mediate interaction of RR.  
While both monomers sit along the same face bound to the DNA the closest distance 
between the two protein monomers was found to be 10.1 Å, indicating that the C-terminal 
domain is not part of the dimerization interface (Sidote et al., 2008). 
Future experiments would ideally include the structure of the full-length LytR 
which would be more beneficial into detailing the dimerization mode of the protein, and 
the effect on the C-terminal domain.  Also, higher resolution of LytRN crystal structures 
could provide more detailed information about the solvent involved in the protein 
stabilization.  Design of a new protein construct that removes residues 119-134, which 
could not be mapped due to the missing electron density and add disorder to the crystal 
packing, could lead to a higher resolution crystal structure.  Lastly, crystallization of the 
protein without the sulfate ion would possibly result in a more representative apo form of 
the protein allowing for comparison with the phosphorylated LytR. 
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5.2 TrbC and TraW from T4SSs 
 The emergence of the antibiotic resistance genes and the evolutionary spread of 
such genes are due to the bacterial T4SSs.  Conjugation, as the most important process 
for bacterial DNA transfer, requires independently replicating conjugative plasmids that 
encode and facilitate their own transfer as well as the transfer of other cellular DNA 
between two cells (Lanka & Wilkins, 1995; Frost et al., 2005).  Genes necessary for 
conjugative single-stranded DNA transfer of the Escherichia coli K-12 fertility factor, F, 
are encoded within the 33.3kb transfer region of this 99.159 kb plasmid, assemble into a 
T4SS machinery.  This system uses an appendage also known as the F pilus for DNA 
transfer into the recipient cells.   
While homologues exist between different plasmid encoded T4SS, TrbC and 
TraW remain unique to the F plasmid of E. coli.  Both proteins are localized in the 
periplasm and are both required for the F pilus assembly and DNA transfer proficiency 
(Anthony et al., 1999; Arutyunov et al., 2010).  In the absence of structural and 
functional information on the proteins, and the low number of published articles on these 
proteins, we endeavoured to study these proteins in detail and determine their structures 
crystallographically.  Both proteins are predicted to have thioredoxin-like properties 
according to their predicted structures.  In addition, both TrbC and TraW are both 
cysteine-containing proteins, which are known to promote proper protein folding and 
assembly of pore complex proteins in the periplasm (Hemmis & Schildbach, 2013), much 
like the F pilus assembly.  
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Our crystallization attempts of both proteins was not entirely successful, possibly 
due to the unstable redox nature of the proteins.  While TrbC exist as a mixture of 
oligomers in solution (which was confirmed by MS), homogenous protein samples were 
obtained only in the presence of GSH.  However due to the low solubility of the protein, 
crystallization of the protein was not acheived.  On the other hand, TraW is crystallizable, 
but the unstable nature of the protein either caused the crystals to dissolve or precipitate.  
This is possibly due to the lone thiol group of the protein from the single unpaired 
cysteine.  For the future, in order to obtain thermally stable TraW the mutation of the lone 
cysteine residue could potentially help.  On the other hand the addition of another 
cysteine residue could have the same positive effect, as seen on oxidized cross-linked 
lysozyme upon addition of double cysteine resides (Matsumura et al.,1989).  This 
however, would be a trial and error method in order to get the right proximity of the two 
cysteine residues.  Since TraW has been shown to interact with TrbB, whose function as a 
disulfide isomerase is also linked with maintaining of free thiols (Harris & Silverman, 
2004; Hemmis & Schildbach, 2013), co-crystallization of the proteins could increase the 
stability of TraW. 
Interaction of TrbC with TraW has been speculated but never experimentally 
shown.  Using SEC and affinity chromatography, we show that the two proteins interact.  
In the absence of a crystallographically determined structure of the TraW-TrbC complex, 
the proteins were found to interact with both free or tagged N-terminal and C-terminal 
ends, our results indicate that these proteins interact in vitro.  However, since the N-
terminally 6-His tagged TraW is co-eluted from the SEC with the untagged TrbC, versus 
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the N-terminally 6-His tagged TrbC, we suggest that TraW prefers interaction with the N-
terminal end of TrbC.  We have attempted to analyze the kinetic properties of the 
interaction between the two proteins using Isothermal Titration Calorimetry, however due 
to the precipitation of the proteins in the cell we were not able to optimize parameters to 
characterize this interaction.  In the future, it would be valuable to determine the redox 
properties of the proteins, this could lead to useful insight on dealing with sensitive 
proteins and help in their crystallization.   
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APPENDIX A 
A.1 Protein X-ray Crystallography  
This brief description of the method of X-ray crystallography was adapted from the 
following excellent reference textbooks: 
1) Crystallization of Biological Macromolecules by Alexander McPherson (1999) 
2) Introduction to Macromolecular Crystallography by Alexander McPherson (2003) 
3) Principles of Protein X-ray Crystallography by Jan Drenth (2007) 
 
 X-ray crystallography is a powerful technique used for direct visualization of 
atomic and molecular structure solution of macromolecules.  Protein structure 
information explains how are the atoms of a molecule arranged relative to one-another in 
three-dimensional space.  Considering that the function of proteins is closely related to its 
structure, X-ray crystallography is a valuable tool for elucidating or confirming 
functional properties of unknown proteins.  The X-ray diffraction of a pure protein crystal 
is collected and analyzed, leading to the information of atomic arrangement of the protein 
structure.  While other methods exist for obtaining macromolecular structure information, 
protein X-ray crystallography is preferred as it in not limited by the size of the 
macromolecule.  The biggest challenge in X-ray crystallography, however, is obtaining 
protein crystals in addition to them being of sufficient quality for structure solution.  In 
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this thesis structures of LytRN and BeF-LytRN complex were determined, while 
crystallization of TrbC and good quality crystals of TraW were more challenging tasks.   
Structures of LytRN were determined by molecular replacement (MR), for this 
reason this method will be explained in more detail.    In general there are four main steps 
in protein X-ray crystallography: a) protein crystallization, b) data collection and 
processing, c) phase determination and structure solution, and d) structure refinement. 
 
A.2 Protein Crystallization   
 Protein crystals, like all other crystals, are precisely ordered three-dimensional 
repetitions of single building block, also known as the unit cell.    The smallest unit of the 
unit cell that cannot be explained by crystallographic symmetry operations, is called the 
asymmetric unit.  On the other hand, perfect packing and arrangement of unit cells is 
termed the symmetric unit and is used to describe crystals via symmetry properties, 
repetitive features, and the distribution of atoms in the unit cell.  The unit cell is defined 
by three repeating vectors: a, b, and c with three angles: α, β, and γ, respectively, between 
them.  According to these parameters crystals may belong to one of the seven crystal 
systems as shown in table A.1, and defined by 32 allowed space groups, containing only 
rotational and/or translational symmetry elements. 
 Crystallization of proteins occurs when proteins are precipitated from a solution, 
and its molecules in an attempt to reach the lowest free-energy state, they pack and 
arrange perfectly, forming crystals.  This principle is followed by all materials not only 
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proteins; however, there are cases when some proteins do not crystallize at all, and 
therefore cannot be used for crystallography.  For perfect molecule packing, the protein 
sample to be crystallized must be of high purity.  The next step involves dissolving the 
proteins in solvent from which they would crystallize; the protein solution is then brought 
to supersaturation, by the addition of a precipitant solution, to induce the crystallization 
process.  The precipitant may be salt, or any organic molecule that will draw water away 
from the protein.  In addition the solubility of the protein is affected by the pH, and 
temperature and for this reason protein crystallization can become complex.  There are 
many methods used to crystallize proteins, while they all follow the general principle to 
supersaturate protein molecules, they vary by how the protein solution and the precipitant 
solutions are mixed.  The most popular method is vapor diffusion, where the protein is 
equilibrated against the precipitant solution (mother liquor) through the vapor phase; this 
can be achieved using either the hanging drop or the sitting drop vapor diffusion, where 
the water as it leaves the protein/precipitant mixture drop it results in protein 
supersaturation and crystallization. Figure A.2, shows the sitting drop vapor equilibration.  
Once crystals are obtained, they have to be prepared for crystal mounting and X-ray 
diffraction analysis.  Usually most of crystals are diffracted at 100 K, in order to reduce 
damage to the protein caused by X-rays.  For this reason they have to be flash frozen or 
vitrified in liquid nitrogen prior to being subjected to X-rays.  When frozen in liquid 
nitrogen the crystal is cooled rapidly so that the mother liquor forms an amorphous glass 
surface around the crystal, protecting it, while a continuous stream of liquid nitrogen is 
used to keep the crystals at ~ 100K during data collection. 
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Figure A.1 The seven crystal systems and the allowed space groups for macromolecules.  
Copied from McPherson, 2003. 
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Figure A.2 The process of vapor equilibration through loss of water vapor to the larger 
volume of reservoir, inducing crystallization when the two are in equilibrium with the 
same concentration of the precipitant in the drop and in the reservoir.  Copied from 
McPherson, 1999. 
  
 
A.3 Data Collection of X-ray Diffraction Data   
The wave nature of X-rays and the ability of crystals to diffract X-rays became 
clear in the early 1900s.  Sir Lawrence Bragg came up with a mathematical equation (1) 
used to describe constructive interference of reflective waves by a series of lattice planes, 
which can also be used to describe reflection of incident X-rays by crystals. 
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nλ = 2dhklsinθhkl      (1) 
Where n is an integer, λ is the wavelength of the incident radiation, dhkl is the 
perpendicular distance between the adjacent reflecting planes, as defined by the Miller 
indices hkl (relative to unit cell), and θhkl is the angle between the incident/reflected 
radiation and the reflecting planes.   
 Electrons have the ability to diffract X-rays.  When electrons are hit by 
electromagnetic radiation, they oscillate at the same frequency as the incident radiation; 
in addition they scatter the radiation with the same frequency as the incident wave 
forming a cloud around the atomic nuclei.  This in turn identifies the location of the 
atoms where the electrons are oscillating.  The Structure factor, (F(S)) (2) is used to 
describe the relation between the molecules and the scattered X-rays of electrons from 
each atom of the molecule. 
 
       (2) 
 
where f is the scattering factor of an atom, r is the position of the atom, and  |S| = 
(2sinθ)/λ.  The magnitude of f j is equal to the number of electrons in a certain atom j, the 
summation of all the scattering factors of atoms in a molecule constitutes to the overall 
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structure factor of the molecule, which is dependent of the types of atoms present as well 
as their position in the unit cell.   
Since the position of electrons may explained in terms of vectors (which have 
both magnitude and direction) the structure factor may then be described in terms of 
vectors, A and B, F(S) = A + iB,  where A=|F(S)|cosα, B=|F(S)|sinα, and |F(S)| is the 
magnitude of the structure factor while α is the phase angle.  Because of the possibility of 
the electron position anywhere surrounding the nucleus, the structure factor can be both 
above or below the horizontal axis, and for electron position below the horizontal axis 
they are represented by F*(S) = A – iB. 
The higher the number of electrons in a molecule the higher the intensity of the 
reflected X-rays, for this reason the intensity is proportional to the product of structure 
factor above and below the horizontal axis (3). 
 
I α F(S)  F*(S)       (3) 
 
Expanding the relations of structure factors in terms of the positions A and B, we get the 
expression for the intensity of the reflection as (4). 
 
I α |F(S)|  eiα  |F(S)|  e-iα     (4) 
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This expression then becomes I α |F(S)|2  e(iα –iα), and it reduces to I α |F(S)|2, 
where the information regarding the phase angle α, is lost.  This is known as the phase 
problem, and for this reason in X-ray crystallography we use, multiple-isomorphous 
replacement (MIR), multiple-wavelength anomalous dispersion (MAD), or molecular 
replacement (MR) for obtaining phase information about the position of the electrons, 
hence atoms in the molecule. 
In X-ray diffraction experiments the relationship between the intensity of the 
observed reflections and the structure factor is also dependent on other factors as shown 
in equation (5). 
 
 (5) 
 
where λ is the wavelength; ω is the angular rotation of the crystal; V is the volume of the 
unit cell; e and m, are the charge and the mass of an electron, and c is the speed of light; 
VCr is the volume of the crystal; IO is the intensity of the incident beam; L is the Lorentz 
factor, which depends on the data collection technique; P is the polarization factor of the 
incident and reflected intensities; and A is the absorption factor and it depends on crystal 
size and composition. 
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A.4 Structure Solution and Phase Determination 
For determining the position of the actual electron density we need the amplitude 
as well as the phase information, which is given by α.  The MIR method requires 
attachment of a heavy atom to the protein molecule in such a manner that the three-
dimensional structure of the protein is not affected by it.  Since macromolecular crystals 
are composed of at least 50% solvent, through diffusion, heavy atoms might reach 
specific amino acid side chains on the molecule and not affect the structure.  The only 
difference between the intensities obtained from the two different forms of crystals would 
be due to the presence of the heavy atoms.  The second method used is MAD, which 
required the incorporation of heavy atoms into the protein structure as well as an X-ray 
source with at least two different wavelength options.  The best way commonly used for 
incorporating the heavy atom is the seleno-methionine (Se-Met), which replaces the 
Sulfur in the Methionine residues, but incorporation of Fe in heme groups, or Zn and Cu 
may work.  This method requires the identification of the positions, the x, y, z coordinates 
of the anomalous scatters, which can be determined by the difference in Patterson maps, 
which use the difference between h,k,l and –h,-k.-l, to locate the atoms within the protein.  
The third method of choice is MR, but available only when similar structures exist.  The 
two structures known and unknown must have sequence similarity and similar folding in 
order for the known structure to be used for the determination of the initial phases of the 
unknown.  This method does not compare structure factors which require both magnitude 
and phase information, rather it uses the Patterson functions P(uvw) of both molecules for 
comparison (6). 
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 (6)  
 
The Patterson function is the square of structure factors, with all the phase angles 
set to zero.  Patterson peaks represent the vectors between two atoms, and are 
proportional to the number of electrons in the atoms between the vectors.  For this reason, 
interatomic vectors (self-Patterson vectors) will be small, whereas vectors between two 
atoms (cross-Patterson vectors) will be large due to the combination of electrons.  Self-
Patterson vectors are used in rotation functions, since they provide information regarding 
the location of the atoms in the unit cell.  Cross-Patterson vectors are used in translation 
functions, providing information on the molecule’s position with respect to the other 
symmetry related molecules in the unit cell.  There are various computer programs that 
successfully can determine the rotational and translational search between the known and 
unknown structures.  The known structure is then placed in the unit cell of the unknown 
structure, and using the known structure coordinates and structure factors, the unknown 
molecule can be used to calculate the structure factors of the unknown crystal.  While this 
is only approximate since the two molecules are not identical, the calculated structure 
factors (FCalc) are compared to the observed structure factors (FObs) suffice in obtaining 
the correct structure solution, after cycles of improvement and refinement.  R-value (7) 
and correlation coefficient (CC) (8) are good indicators of how correct are the structure 
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solution by comparing the differences between the observed and calculated structure 
factors. 
 
     (7) 
 
The closer FCalc resembles FObs, the lower R-value becomes lower, values of less that 25% 
are normally accepted. 
 
 (8) 
 
On the other hand, the closer the CC value is to 1 the more closely does the FCacl 
represent FObs. 
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A.5 Structure Refinement  
  After obtaining the phase information of the structure must be refined.  This is 
done by fitting the structure into the observed electron density, as well as the addition of 
other structural components such as ligands, waters and other solvent molecules.  The 
model building can be done using a computer program such as COOT, and refinement 
with Refmac, which calculates how close are the calculated structure factors to those 
observed using R-values (7).  To confirm correct structure solutions Rfree was introduced 
which uses a randomly chosen 5-10% of the observed reflections and compares them to 
the calculated structure factors, and as such it is unbiased by the refinement process 
(Brünger, 1993a).  In the final stages of the structure refinement there are various 
software packages such as SFCHECK, PROCHECK, and EBI-PISA that are used to 
validate the structure, including bond lengths, ligands, and the correct stereochemistry of 
the amino acids. 
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APPENDIX B 
 
 
Protein sequence and relevant statistics for the proteins studied in this 
Dissertation 
 
TrbC-His7 (Full length TrbC, with a C terminal 7His tag) 
 
        10         20         30         40         50         60  
MASENVNTPE NRQFLKQQEN LSRQLREKPD HQLKAWAEKQ VLENPLQRSD NHFLDELVRK  
 
        70         80         90        100        110        120  
QQASQDGKPR QGALYFVSFS IPEEGLKRML GETRHFGIPA TLRGMVNNDL KTTAEAVLSL  
 
       130        140        150        160        170        180  
VKDGATDGVQ IDPTLFSQYG IRTVPALVVF CSQGYDIIRG NLRVGQALEK VAATGDCRQV  
 
       190        200  
AHDLLAGKGD SGKGSHHHHH HH  
 
Number of amino acids 202 
Molecular weight  22532.3 Da 
Theoretical pI   7.88 
Abs (1 g/l)   0.448 
 
His6-TrbC (Full length TrbC, with a cleavable N terminal 6His tag) 
        10           20         30         40         50         60  
MGSSHHHHHH SSGLVPR||GSH MSENVNTPEN RQFLKQQENL SRQLREKPDH QLKAWAEKQV  
 
        70         80         90        100        110        120  
LENPLQRSDN HFLDELVRKQ QASQDGKPRQ GALYFVSFSI PEEGLKRMLG ETRHFGIPAT  
 
       130        140        150        160        170        180  
LRGMVNNDLK TTAEAVLSLV KDGATDGVQI DPTLFSQYGI RTVPALVVFC SQGYDIIRGN  
 
       190        200        210  
LRVGQALEKV AATGDCRQVA HDLLAGKGDS GK  
 
Number of amino acids 212 
Molecular weight  23520.4 Da 
Theoretical pI   8.56 
Abs (1 g/l)   0.429   | | TEV protease cleavage site 
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TrbC (Full length TrbC, with a cleaved tag) 
        10         20         30         40         50         60  
GSHMSENVNT PENRQFLKQQ ENLSRQLREK PDHQLKAWAE KQVLENPLQR SDNHFLDELV  
 
        70         80         90        100        110        120  
RKQQASQDGK PRQGALYFVS FSIPEEGLKR MLGETRHFGI PATLRGMVNN DLKTTAEAVL  
 
       130        140        150        160        170        180  
SLVKDGATDG VQIDPTLFSQ YGIRTVPALV VFCSQGYDII RGNLRVGQAL EKVAATGDCR  
 
       190  
QVAHDLLAGK GDSGK  
 
 
Number of amino acids 195 
Molecular weight  21638.4  Da 
Theoretical pI   7.97 
Abs (1 g/l)   0.467 
 
TrbCC-His6 (C terminal domain TrbC, with a C terminal 6His tag) 
        10         20         30         40         50         60  
MGEEGLKRML GETRHFGIPA TLRGMVNNDL KTTAEAVLSL VKDGATDGVQ IDPTLFSQYG  
 
        70         80         90        100        110        120  
IIRTVPALVV FCSQGYDIIR GNLRVGQALE KVAATGDCRQ VAHDLLAGKG DSGKLEHHHH  
 
 
HH  
 
 
Number of amino acids 122 
Molecular weight  1318.0  Da 
Theoretical pI   6.70 
Abs (1 g/l)   0.236 
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TraW-His7 (Full length TraW, with a C terminal 7His tag) 
        10         20         30         40         50         60  
MADLGTWGDL WPVKEPDMLT VIMQRLTALE QSGEMGRKMD AFKERVIRNS LRPPAVPGIG  
 
        70         80         90        100        110        120  
RTEKYGSRLF DPSVRLAADI RDNEGRVFAR QGEVMNPLQY VPFNQTLYFI NGDDPAQVAW  
 
       130        140        150        160        170        180  
MKRQTPPTLE SKIILVQGSI PEMQKSLDSR VYFDQNGVLC QRLGIDQVPA RVSAVPGDRF  
 
       190        200  
LKVEFIPAEE GRKGSHHHHH HH  
 
 
Number of amino acids 202 
Molecular weight  22925.2  Da 
Theoretical pI   7.93 
Abs (1 g/l)   0.980 
 
His6-TraW (Full length TraW, with a cleavable N terminal 6His tag) 
        10           20         30         40         50         60  
MGSSHHHHHH SSGLVPR||GSH MADLGTWGDL WPVKEPDMLT VILQRLTALE QSGEMGRKMD  
 
        70         80         90        100        110        120  
AFKERVIRYS LRPPAVPGIG RTEKYGSRLF DPSVRLAADI RNNEGRVFAR QGEVMNPPQY  
 
       130        140        150        160        170        180  
VPFNQTLYFI NGDDPAQVAW MKRQTPPTLE SKIILVQGSI PEMQKSLDSR VYFDQNGVLC  
 
       190        200        210  
QRLGIDQVPA RVSAVPGDRF LKVEFIPAEE GRK  
 
 
Number of amino acids 213 
Molecular weight  23998.4  Da 
Theoretical pI   9.06 
Abs (1 g/l)   0.998   | | TEV protease cleavage site 
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TraW  (Full length TraW, with a cleaved tag) 
        10         20         30         40         50         60  
GSHMADLGTW GDLWPVKEPD MLTVILQRLT ALEQSGEMGR KMDAFKERVI RYSLRPPAVP  
 
        70         80         90        100        110        120  
GIGRTEKYGS RLFDPSVRLA ADIRNNEGRV FARQGEVMNP PQYVPFNQTL YFINGDDPAQ  
 
       130        140        150        160        170        180  
VAWMKRQTPP TLESKIILVQ GSIPEMQKSL DSRVYFDQNG VLCQRLGIDQ VPARVSAVPG  
 
       190  
DRFLKVEFIP AEEGRK  
 
Number of amino acids 196 
Molecular weight  22116.4  Da 
Theoretical pI   8.72 
Abs (1 g/l)   1.083 
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MBP-TrbC (Full length TrbC, with an N terminal MBP tag) 
        10         20         30         40         50         60  
MKIKTGARIL ALSALTTMMF SASALAKIEE GKLVIWINGD KGYNGLAEVG KKFEKDTGIK  
 
        70         80         90        100        110        120  
VTVEHPDKLE EKFPQVAATG DGPDIIFWAH DRFGGYAQSG LLAEITPDKA FQDKLYPFTW  
 
       130        140        150        160        170        180  
DAVRYNGKLI AYPIAVEALS LIYNKDLLPN PPKTWEEIPA LDKELKAKGK SALMFNLQEP  
 
       190        200        210        220        230        240  
YFTWPLIAAD GGYAFKYENG KYDIKDVGVD NAGAKAGLTF LVDLIKNKHM NADTDYSIAE  
 
       250        260        270        280        290        300  
AAFNKGETAM TINGPWAWSN IDTSKVNYGV TVLPTFKGQP SKPFVGVLSA GINAASPNKE  
 
       310        320        330        340        350        360  
LAKEFLENYL LTDEGLEAVN KDKPLGAVAL KSYEEELAKD PRIAATMENA QKGEIMPNIP  
 
       370        380        390        400        410          420  
QMSAFWYAVR TAVINAASGR QTVDEALKDA QTNSSSNNNN NNNNNNLGIE GR||ISEFASEN  
 
       430        440        450        460        470        480  
VNTPENRQFL KQQENLSRQL REKPDHQLKA WAEKQVLENP LQRSDNHFLD ELVRKQQASQ  
 
       490        500        510        520        530        540  
DGKPRQGALY FVSFSIPEEG LKRMLGETRH FGIPATLRGM VNNDLKTTAE AVLSLVKDGA  
 
       550        560        570        580        590        600  
TDGVQIDPTL FSQYGIRTVP ALVVFCSQGY DIIRGNLRVG QALEKVAATG DCRQVAHDLL  
 
       610  
AGKGDSGKGS  
 
Number of amino acids 610 
Molecular weight  66930.8  Da 
Theoretical pI   5.75 
Abs (1 g/l)   1.142     | | Xa Protease cleavage site 
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